Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1050.Time spend outdoors in summer,47086,0.0523788668623379,0.0396427852790173,-0.0253209922845361,0.130078726009212,0.186427880537248
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1060.Time spent outdoors in winter,45264,0.0170715320078765,0.0438614415651404,-0.0688968934597988,0.103039957475552,0.6971222483666
CCND2,G1/S-specific cyclin-D2,Physical activities,X1070.Time spent watching television (TV),48126,-0.113050751751214,0.0404984004028202,-0.192427616540742,-0.0336738869616868,0.00525190511515679
CCND2,G1/S-specific cyclin-D2,Physical activities,X1080.Time spent using computer,45276,-0.0907767764354593,0.0392081287562378,-0.167624708797685,-0.0139288440732331,0.0206115588820792
CCND2,G1/S-specific cyclin-D2,Physical activities,X1090.Time spent driving,41728,0.0429555333514043,0.0461328466253035,-0.0474648460341904,0.133375912736999,0.351805872850665
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1160.Sleep duration,48800,0.00827911229466446,0.0353847764762578,-0.0610750495988008,0.0776332741881297,0.815007724949005
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34691,-0.0031939599155336,0.0168040509456667,-0.0361298997690402,0.029741979937973,0.849260645672953
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34691,-0.00741973166852298,0.0160919027043255,-0.038959860969001,0.024120397631955,0.64475601182839
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34691,0.0202564592327998,0.0175006174140743,-0.0140447508987859,0.0545576693643854,0.247130223017582
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34691,-0.000771434805828528,0.0176932223552086,-0.0354501506220374,0.0339072810103803,0.965224370766797
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34691,-0.0196028847288868,0.017693653183284,-0.0542824449681233,0.0150766755103498,0.267951371028398
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34691,-0.0607395467215565,0.045707871169933,-0.150326974214625,0.0288478807715123,0.183947982700782
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34691,-0.0189890998455273,0.0467585833640354,-0.110635923239037,0.0726577235479821,0.68467803319391
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34691,-0.00759590812647874,0.0312733928185583,-0.0688917580508531,0.0536999417978956,0.808101811330542
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34691,-0.00172332865861883,0.0223459590692054,-0.0455214084342615,0.0420747511170238,0.938530594082216
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34691,-0.0204080463186243,0.0144425655704048,-0.0487154748366177,0.0078993821993691,0.157698068260771
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34691,0.00418927607722555,0.0217603252739287,-0.0384609614596747,0.0468395136141258,0.847342797582724
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34691,0.00232884216987095,0.0117182718279552,-0.0206389706129212,0.0252966549526631,0.842476631445108
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34691,-0.0337137277010078,0.0151077392835685,-0.063324896696802,-0.00410255870521363,0.0256846506128252
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34691,-0.0066873808661222,0.0215901892659215,-0.0490041518273283,0.0356293900950839,0.756769167286597
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34691,-0.0150515953496422,0.0204062458563729,-0.0550478372281331,0.0249446465288486,0.460790575617
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34691,-0.0204333901685918,0.0312848953135934,-0.0817517849832347,0.0408850046460512,0.51369388572707
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34691,-0.0337746606172644,0.0299648499240513,-0.092505766468405,0.0249564452338762,0.259731367858012
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34691,0.000896942141246859,0.0158497539940429,-0.0301685756870772,0.0319624599695709,0.954873628042588
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34691,-0.0127499512854444,0.0150494881692344,-0.0422469480971439,0.0167470455262551,0.396919614157683
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34691,-0.000712259773477127,0.0190627342101099,-0.0380752188252925,0.0366506992783382,0.970196142723113
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120040.Fatigue severity over the past week,34696,-0.110489317652437,0.068882856377151,-0.245499716151653,0.0245210808467785,0.108767578540557
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34695,-0.105939749465513,0.0687155537719981,-0.240622234858629,0.0287427359276032,0.123200583835391
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34695,0.0471362156067768,0.073728084755437,-0.0973708305138798,0.191643261727433,0.522638089630274
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120098.Mobility problems today,34699,-0.0987581774008695,0.0760426965084997,-0.247801862557529,0.0502855077557898,0.194094434875769
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120099.Self-care problems today,34699,-0.022011872125105,0.116311835967469,-0.249983070621343,0.205959326371133,0.849904824242027
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120100.Problems doing usual activities,34699,-0.0604383540704082,0.0739744601705139,-0.205428296004616,0.0845515878637991,0.413954377210698
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120101.Pain or discomfort today,34699,-0.0709439102407871,0.0685287439296017,-0.205260248342806,0.0633724278612322,0.300600886813677
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120102.Anxiety or depression today,34699,-0.0769245523690517,0.0865140024594755,-0.246491997189624,0.0926428924515202,0.37395744777951
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120103.Scale to indicate how health is today,34679,0.00301009253639739,0.00510892494206007,-0.00700340035004036,0.0130235854228351,0.555762677760574
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34677,-0.0820859613193252,0.0886559418383611,-0.255851607322513,0.0916796846838626,0.354542088206066
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34666,-0.11963078952716,0.0918650397975331,-0.299686267530325,0.0604246884760049,0.192887472836695
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34682,0.00850590765412993,0.0693788003495948,-0.127476541031076,0.144488356339336,0.902427583551326
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34684,-0.0167527242058113,0.0712216553948295,-0.156347168779677,0.122841720368054,0.814047125673684
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34692,0.00675115180324513,0.102187802489674,-0.193536941076516,0.207039244683006,0.947327585764746
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34674,-0.00498482956959168,0.09947634415421,-0.199958464111843,0.18998880497266,0.960035997369333
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34687,-0.115224251022644,0.0982608492035112,-0.307815515461526,0.077367013416238,0.240992504640675
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34684,-0.2097279831227,0.138527228522197,-0.481241351026206,0.0617853847808066,0.130087528424571
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34663,-0.0497945114491006,0.205896620291537,-0.453351887220514,0.353762864322313,0.808911434452572
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32839,-0.0628095691966044,0.0967047288282757,-0.252350837700025,0.126731699306816,0.516057210778564
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,47240,-0.0503915657780823,0.0862922166565034,-0.219524310424829,0.118741178868664,0.559251693666499
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45747,-0.0979176590632556,0.0528010630908731,-0.201407742721367,0.00557242459485568,0.0636906104696325
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1289.Cooked vegetable intake,48407,0.000960595158134474,0.0372045087549193,-0.0719602420015074,0.0738814323177764,0.979401719131619
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47722,-0.0166991843536236,0.0386538749207655,-0.092460779198324,0.0590624104910769,0.665733083593378
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1309.Fresh fruit intake,48358,-0.00198802036693293,0.0380369798534916,-0.0765405008797765,0.0725644601459106,0.958317716920457
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1319.Dried fruit intake,47332,-0.0245074442046204,0.0382681138079328,-0.0995129472681686,0.0504980588589279,0.5219114317977
CCND2,G1/S-specific cyclin-D2,Health and medical history,X134.Number of self-reported cancers,48977,0.0187342626139074,0.0592120325081071,-0.0973213211019825,0.134789846329797,0.751707696160774
CCND2,G1/S-specific cyclin-D2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48978,-0.116516534418354,0.038440086339331,-0.191859103643442,-0.041173965193265,0.00243962994300876
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X136.Number of operations, self-reported",48978,-0.0633979497967313,0.0368815048875022,-0.135685699376235,0.00888979978277298,0.0856367162853367
CCND2,G1/S-specific cyclin-D2,Health and medical history,X137.Number of treatments or medications taken,48978,-0.0795248442289637,0.0368360473617927,-0.151723497058077,-0.00732619139984994,0.0308709608303469
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1438.Bread intake,48442,0.0102282061984072,0.00291511097655919,0.00451458868435122,0.0159418237124632,0.000451355650000123
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1458.Cereal intake,48168,0.0604572454591988,0.0361208952496251,-0.0103397092300665,0.131254200148464,0.0941967869042358
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1488.Tea intake,48371,0.00219049410736155,0.00281574070142634,-0.00332835766743408,0.00770934588215718,0.436610468520755
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1498.Coffee intake,47524,0.0145258023934253,0.036560931614009,-0.0571336235700323,0.0861852283568829,0.691147964320428
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1528.Water intake,47422,-0.0324487837662245,0.0367980070646393,-0.104572877612918,0.0396753100804686,0.377892173695781
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1568.Average weekly red wine intake,42711,-0.0709836027439349,0.0418458565676376,-0.153001481616505,0.0110342761286348,0.089849953927021
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42711,-0.0118760241856441,0.0430764658252012,-0.0963058972030385,0.0725538488317504,0.782785517832585
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42749,-0.0119823983420473,0.0484711275725621,-0.106985808384269,0.0830210117001745,0.804751831333766
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1598.Average weekly spirits intake,42694,-0.0536420703053191,0.0450553882859702,-0.141950631345821,0.0346664907351825,0.23383921503306
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1608.Average weekly fortified wine intake,42736,0.0417058721642478,0.0684010972645952,-0.0923602784743587,0.175772022802854,0.542054094502129
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1737.Childhood sunburn occasions,43591,-0.00811478760254432,0.044368356009622,-0.0950767653814034,0.0788471901763147,0.854882325020676
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1807.Father's age at death,47181,-0.00148866392318051,0.00270881955418556,-0.00679795024938421,0.00382062240302319,0.582626744835216
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1845.Mother's age,32122,-0.00506625586805514,0.0127682276918884,-0.0300919821441565,0.0199594704080462,0.69155408429665
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1873.Number of full brothers,48622,0.0450149455053258,0.0350855524329475,-0.0237527372632513,0.113782628273903,0.199505567216789
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1883.Number of full sisters,48626,-0.0654026580513287,0.0349869046347837,-0.133976991135505,0.00317167503284733,0.0615896111371261
CCND2,G1/S-specific cyclin-D2,Physical measures,X20015.Sitting height,48837,-0.000743706895929657,0.00362480934778261,-0.00784833321758357,0.00636091942572425,0.837440406941683
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20016.Fluid intelligence score,35747,-0.079295393980886,0.0597235239421509,-0.196353500907502,0.0377627129457298,0.1843209581114
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20018.Prospective memory result,36039,0.0823160974487456,0.0731669814639258,-0.0610911862205489,0.22572338111804,0.260609703980477
CCND2,G1/S-specific cyclin-D2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35623,-0.00107785273265962,0.00467629269131039,-0.010243386407628,0.00808768094230875,0.817716035854013
CCND2,G1/S-specific cyclin-D2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35606,-0.00102177617291122,0.00472371489131919,-0.0102802573598968,0.0082367050140744,0.828754743929961
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20023.Mean time to correctly identify matches,48725,0.00208656851919995,0.00296812964229304,-0.00373096557969442,0.00790410261809431,0.48206971760872
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#1.Illnesses of father_Heart disease,46062,-0.0031428977335049,0.00619187864578383,-0.0152789798792412,0.0089931844122314,0.611751840384158
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45696,-0.0134601964940769,0.0129810351180574,-0.0389030253254694,0.0119826323373157,0.299791870361741
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45662,0.00572807324338688,0.0175884396029145,-0.0287452683783256,0.0402014148650994,0.744676198078136
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45671,-0.00444706340640634,0.0167155042022461,-0.0372094516428086,0.028315324829996,0.790208475986786
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45697,0.0167170974118706,0.011522727172127,-0.00586744784549845,0.0393016426692396,0.146856383108451
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#2.Illnesses of father_Stroke,45837,0.00743253055069045,0.00778793886208345,-0.00783182961899312,0.022696890720374,0.339913149059667
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45796,-0.00651917113822967,0.00949757390048488,-0.02513441598318,0.0120960737067207,0.492468073606814
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45704,-0.0140178925953845,0.0122490332763951,-0.0380259978171188,0.00999021262634982,0.252471031568571
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45846,0.000456922889196257,0.00838517123208519,-0.0159780127256907,0.0168918585040832,0.956544012779862
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45838,0.0154646030700525,0.00779186583367294,0.000192546036053527,0.0307366601040514,0.0471930080012213
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45728,0.0329644430319952,0.0111696297436399,0.011071968734461,0.0548569173295294,0.0031692808638389
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46983,-0.00958254907812516,0.0067430836349107,-0.0227989930025501,0.00363389484629981,0.155307248055176
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46846,-0.0130670294533406,0.00883801583532524,-0.0303895404905781,0.00425548158389683,0.139291142798824
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46769,-0.0181192342939041,0.0197924276095186,-0.0569123924085606,0.0206739238207525,0.35996120109348
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46791,0.00201394650379004,0.0122671714843316,-0.0220297096054999,0.02605760261308,0.869596317506455
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46936,0.0030250493220056,0.00739381392514003,-0.0114668259712689,0.0175169246152801,0.682447390632788
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46808,-0.00438686620587537,0.0142255170013029,-0.0322688795284291,0.0234951471166784,0.757796777276731
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46796,-0.00761328809360403,0.012029417926872,-0.0311909472302732,0.0159643710430652,0.526814254961471
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46800,-0.00614676641390518,0.0106190496600936,-0.0269601037476886,0.0146665709198783,0.562702274019247
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46841,-0.00853009965052743,0.0117966720258393,-0.0316515768211724,0.0145913775201176,0.469631880737849
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46973,-0.00129697203794977,0.00657100398187394,-0.0141761398424227,0.0115821957665232,0.843533951477094
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46858,0.0123792195759945,0.0100859951582815,-0.00738933093423713,0.0321477700862262,0.2197009676269
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43772,0.00393927485497287,0.00850603161020693,-0.0127325471010327,0.0206110968109785,0.643288512767925
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43613,-0.0185066024120676,0.0297730108939945,-0.0768617037642968,0.0398484989401616,0.53422140101438
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43608,-0.00724022147602559,0.0314666961365983,-0.0689149459037583,0.0544345029517071,0.81802388147771
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43637,-0.0102066701919851,0.0131243251083525,-0.035930347404356,0.0155170070203858,0.436763907294236
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43627,0.025583701524929,0.0177471251798911,-0.00920066382765758,0.0603680668775155,0.149445758162135
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43658,-0.00507135906921435,0.0141300539329079,-0.0327662647777138,0.0226235466392851,0.719670759042598
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43628,-0.00989144704170919,0.0159625657679742,-0.0411780759469387,0.0213951818635203,0.535487990694527
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43621,-0.0237483209771968,0.0161627006867737,-0.0554272143232733,0.00793057236887967,0.141765444163923
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43640,-0.0200348386855178,0.0130124306907684,-0.0455392028394239,0.00546952546838832,0.123662911910212
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43658,0.00372416286588832,0.0155946343396162,-0.0268413204397594,0.034289646171536,0.811255889310637
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43804,-0.0109550873758811,0.0071825487575594,-0.0250328829406975,0.00312270818893537,0.127221701126305
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43714,-0.0159051328360864,0.00985032176322643,-0.0352117634920102,0.00340149781983742,0.106401402567508
CCND2,G1/S-specific cyclin-D2,Mental health,X20127.Neuroticism score,44738,0.025465185045094,0.0371333136707101,-0.0473161097494979,0.0982464798396859,0.492863763102807
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35747,-0.082639772875736,0.0604869141081875,-0.201194124527783,0.0359145787763115,0.171909924144298
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20161.Pack years of smoking,35910,-0.00566308729468731,0.00486868333197992,-0.015205706625368,0.00387953203599334,0.244803446042466
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35910,-0.00588304814931397,0.00503107673321672,-0.0157439585464187,0.00397786224779081,0.242307455247487
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20191.Fluid intelligence score,33572,0.114577891781127,0.0705399725450567,-0.0236804544071844,0.252836237969438,0.10438454336133
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33573,0.0944838795579648,0.0723888080609401,-0.0473981842414778,0.236365943357407,0.191884079571168
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20240.Maximum digits remembered correctly,33029,-0.0168682039195211,0.0757026937264774,-0.165245483623417,0.131509075784375,0.823686159275814
CCND2,G1/S-specific cyclin-D2,Physical measures,X20255.Spirometry QC measure,43839,0.0381072023911059,0.0464221447715096,-0.0528802013610529,0.129094606143265,0.411725625530897
CCND2,G1/S-specific cyclin-D2,Eye measures,X20261.avMSE,33671,-0.00625101207552953,0.00526368455937005,-0.0165678338118948,0.00406580966083577,0.235064501831998
CCND2,G1/S-specific cyclin-D2,Eye measures,X20262.Myopia diagnosis,33671,0.0661772865770837,0.0950210738902715,-0.120064018247848,0.252418591402016,0.486184148000859
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20280.Glucose-lactate,40273,-0.00386949054607663,0.00367081104156039,-0.011064280187535,0.00332529909538175,0.291849071428
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40296,-0.00465013532115861,0.00376827857731952,-0.0120359613327049,0.00273569069038765,0.21722115900565
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35379,0.00835665904428684,0.0224561744162615,-0.0356574428115858,0.0523707609001595,0.709807389233986
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35379,0.024469093962279,0.0420074826106145,-0.0578655719545254,0.106803759879083,0.560255417404829
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35379,0.0565411256678963,0.0676366780023418,-0.0760267632166936,0.189109014552486,0.403213289789188
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35379,-0.0194224027449395,0.020684414958678,-0.0599638560639484,0.0211190505740695,0.347773937025777
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35379,0.0462340511702518,0.0434752149347088,-0.0389773701017773,0.131445472442281,0.287615965346198
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35382,-0.0940369701669888,0.0530897020698782,-0.19809278622395,0.0100188458899726,0.0765626032405682
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35382,-0.0318904184315367,0.0341005458476747,-0.0987274882929792,0.0349466514299057,0.349727957002517
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35382,-0.0209906009094967,0.0400816967069012,-0.099550726455023,0.0575695246360295,0.600509157365453
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35382,-0.081655277697677,0.061983940849694,-0.203143801763077,0.0398332463677232,0.187766144320656
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35382,-0.118188058350529,0.0721994118669455,-0.259698905609742,0.0233227889086847,0.101688204090331
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35382,-0.042156183788503,0.0440456111052969,-0.128485581554885,0.0441732139778788,0.338552691352233
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35382,-0.110581851688389,0.0734903622934732,-0.254622961783597,0.0334592584068185,0.132449097729154
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35382,-0.0532220653381668,0.0512136280524908,-0.153600776321049,0.0471566456447152,0.298744497990253
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35382,0.0018962053224271,0.0735248492349443,-0.142212499178064,0.146004909822918,0.979425675496404
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35382,-0.0266017374879709,0.0279885547849203,-0.0814593048664147,0.028255829890473,0.341920484801752
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35382,0.0346156068361581,0.0521435717755917,-0.0675857938440016,0.136817007516318,0.506809865560425
CCND2,G1/S-specific cyclin-D2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35383,0.0356798385274603,0.090077915344621,-0.140872875547997,0.212232552602917,0.692045107319585
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20600.Liking for adding salt to foods,35247,-0.0444938188451367,0.0598961756071665,-0.161890323035183,0.0729026853449097,0.457601928811694
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20601.Liking for aniseed,35247,-0.0519037395984115,0.0586119244499519,-0.166783111520317,0.0629756323234942,0.375895755437423
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20602.Liking for apple juice,35247,-0.0342157865744656,0.0580983141372484,-0.148088482283472,0.0796569091345412,0.555930859997576
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20603.Liking for apples,35247,0.0041513315161879,0.0595567640566303,-0.112579926034807,0.120882589067183,0.94443173990676
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20604.Liking for asparagus,35247,0.00129060503573745,0.0608165892447682,-0.117909909884008,0.120491119955483,0.983069850560531
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20605.Liking for aubergine,35247,-0.148185162396862,0.0592175567259439,-0.264251573579712,-0.0321187512140121,0.0123621524567336
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20606.Liking for avocados,35247,-0.0402270235617447,0.0591944461969957,-0.156248138107856,0.0757940909843669,0.496800080398837
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20607.Liking for bacon,35247,0.0345868335760331,0.0589355998712197,-0.0809269421715575,0.150100609323624,0.557320937940207
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20608.Liking for baked or steamed fish,35247,-0.00869411503897533,0.0591390504945744,-0.124606654008341,0.107218423930391,0.883127919761876
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20609.Liking for bananas,35247,0.0774795014403641,0.0599775153889562,-0.0400764287219902,0.195035431602718,0.196472650209356
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35247,-0.00671409311897025,0.0579193850444131,-0.12023608780602,0.106807901568079,0.907718728602471
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20611.Liking for beef steak,35247,-0.0691363456956387,0.058647331685608,-0.18408511579943,0.0458124244081529,0.238504731918576
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20612.Liking for beetroot,35247,-0.0553239088898122,0.0612369576342188,-0.175348345852881,0.0647005280732567,0.366328494326144
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20613.Liking for bell pepper,35247,-0.0331966724609785,0.0588554626783317,-0.148553379310509,0.0821600343885516,0.572749719536649
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20614.Liking for bicycling,35247,-0.0103338178408655,0.060008182215889,-0.127949854984008,0.107282219302277,0.863280707197743
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20615.Liking for biscuits,35247,0.062563450915339,0.0593330777127895,-0.0537293814017284,0.178856283232406,0.291721503126959
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20616.Liking for bitter foods,35247,-0.0709903250410081,0.0592648575185757,-0.187149445777416,0.0451687956954001,0.231022945112823
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20617.Liking for bitter or ale,35247,-0.0432311027529123,0.0612369537474181,-0.163255532097852,0.0767933265920271,0.480237553011824
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20618.Liking for black olives,35247,-0.119854332295032,0.0597116594300243,-0.236889184777879,-0.0028194798121841,0.0447708713816087
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20619.Liking for black pepper,35247,-0.0192723740062228,0.0584275064815417,-0.133790286710045,0.0952455386975989,0.741523947498617
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20620.Liking for blue cheese,35247,-0.105016948756754,0.0582805227330293,-0.219246773313491,0.00921287579998362,0.07160750768073
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20621.Liking for bolognese sauce,35247,-0.000698835337693651,0.0602171071336589,-0.118724365319665,0.117326694644278,0.99074093107101
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20622.Liking for broad beans,35247,0.0416856968990334,0.0599321976329586,-0.0757814104615654,0.159152804259632,0.48673892619589
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20623.Liking for broccoli,35247,-0.000885597964727402,0.0597979104683793,-0.118089502482751,0.116318306553296,0.988184371691572
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20624.Liking for brown rice,35247,0.0108594695879346,0.0584429568125078,-0.103688725764581,0.12540766494045,0.852597531549603
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20625.Liking for brussel sprouts,35247,-0.078664781489295,0.0587579463314585,-0.193830356298954,0.0365007933203638,0.180688121497826
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20626.Liking for burgers (meat),35247,-0.0190565426650682,0.0583496200915125,-0.133421798044433,0.0953087127142963,0.743987498450198
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20627.Liking for burn of spicy foods,35247,-0.0608909206586467,0.0578556301943045,-0.174287955839483,0.05250611452219,0.292629168468928
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20628.Liking for butter on bread,35247,0.0115304344070548,0.0591759962881661,-0.104454518317751,0.12751538713186,0.845517039259885
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20629.Liking for butternut squash,35247,-0.0638750287151489,0.058242941245556,-0.178031193556439,0.0502811361261408,0.272816287013482
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20630.Liking for cabbage,35247,-0.14487613658847,0.0601585280705109,-0.262786851606671,-0.0269654215702685,0.0160594179873047
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20631.Liking for cake,35247,0.0880758177261674,0.0601043788226863,-0.0297287647662978,0.205880400218633,0.142869001730131
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20632.Liking for cake icing,35247,-0.0141826514730742,0.0589679948714762,-0.129759921421168,0.101394618475019,0.809939664296349
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20633.Liking for capers,35247,-0.121536551308193,0.0581862240651198,-0.235581550475828,-0.00749155214055805,0.0367718513991504
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20634.Liking for cauliflower,35247,-0.0289659886611076,0.0608957528031457,-0.148321664155273,0.0903896868330579,0.634330128690898
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20635.Liking for cereal or granola bar,35247,0.0729024948540541,0.0581126592385201,-0.0409983172534453,0.186803306961553,0.209707812335732
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20636.Liking for cheesecake,35247,0.10932112247668,0.0598969085063189,-0.00807681819570538,0.226719063149065,0.0680270218765677
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20637.Liking for cherries,35247,0.0799668219260276,0.061582480623615,-0.0407348400962578,0.200668483948313,0.194154128629465
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20638.Liking for chicken,35247,0.113964861679327,0.0629353270465494,-0.00938837933190967,0.237318102690564,0.0702175800854608
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20639.Liking for chilli pepper,35247,-0.153311045513561,0.0597197575715106,-0.270361770353722,-0.0362603206734006,0.0102769416215757
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20640.Liking for chips or french fries,35247,0.0844036022167433,0.0595108365246983,-0.0322376373716654,0.201044841805152,0.156157780967309
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20641.Liking for cigarette smoking,35247,-0.0555055015355249,0.10198697099659,-0.255399964688841,0.144388961617792,0.586295647364256
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20642.Liking for cod,35247,-0.00814957769078359,0.0601319000715695,-0.12600810183106,0.109708946449493,0.892198657798637
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20643.Liking for coffee with sugar,35247,0.0214974434675359,0.0642638318786966,-0.104459667014709,0.147454553949781,0.737999907412805
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20644.Liking for coffee without sugar,35247,-0.140170096697342,0.0615518637443586,-0.260811749636285,-0.0195284437583988,0.0228050021244161
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20645.Liking for coriander,35247,-0.0750887922509474,0.0601841721809476,-0.193049769725605,0.0428721852237099,0.212207536428858
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20646.Liking for corn flakes,35247,0.155579080562216,0.0587879834921979,0.0403546329175082,0.270803528206924,0.00815539026765382
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20647.Liking for cream,35247,0.0946785503572937,0.0599047706677879,-0.0227348001515705,0.212091900866158,0.114048323629428
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20648.Liking for croissant,35247,-0.0499822793132829,0.0576608424790082,-0.162997530572139,0.0630329719455732,0.38606832573926
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20649.Liking for cucumber,35247,-0.0305032623539542,0.0611003534791458,-0.15025995517308,0.0892534304651716,0.617634001029803
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20650.Liking for curry,35247,-0.126609163538625,0.0590943995639471,-0.242434186683961,-0.0107841403932886,0.0321938974848601
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20651.Liking for dairy products,35247,0.0786747598013188,0.0608860570396378,-0.0406619119963712,0.198011431599009,0.196349821875798
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20652.Liking for dark chocolate,35247,-0.0453339238736047,0.0606185421153418,-0.164146266419675,0.0734784186724652,0.454576280887982
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35247,-0.0811892615905032,0.0608771602407237,-0.200508495662322,0.0381299724813152,0.182366491432452
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20654.Liking for dried fruit,35247,0.0741671576924769,0.0596652379949678,-0.0427767087776599,0.191111024162614,0.213895876068711
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20655.Liking for eggs,35247,-0.0949831357457688,0.0600066651262012,-0.212596199393123,0.0226299279015856,0.113501953856748
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20656.Liking for exercising alone,35247,0.0617432352805237,0.0605688010801135,-0.0569716148364988,0.180458085397546,0.308058613113992
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20657.Liking for exercising with others,35247,-0.0107018730938479,0.0601773391709256,-0.128649457868862,0.107245711681166,0.85885543938931
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35247,-0.06960173042796,0.0591834606448688,-0.185601313291903,0.0463978524359829,0.23962782209578
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20659.Liking for fatty foods,35247,0.0287113772368204,0.060043977582237,-0.0889748188243641,0.146397573298005,0.632544747622106
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20660.Liking for fresh tomatoes,35247,-0.0553257801719343,0.0625939257645159,-0.178009874670386,0.0673583143265169,0.376793900076694
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20661.Liking for fried chicken,35247,0.0829420610905232,0.0584689817277627,-0.0316571430958917,0.197541265276938,0.156077386584203
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20662.Liking for fried or battered fish,35247,0.0313295581285116,0.0588842135015242,-0.0840835003344759,0.146742616591499,0.594708424711658
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20663.Liking for fruit,35247,-0.0912796192985301,0.0687360859506586,-0.226002347761821,0.0434431091647607,0.184237399539692
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20664.Liking for garlic,35247,-0.0646090099947514,0.0599751150884624,-0.182160235568138,0.0529422155786348,0.281405501718921
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20665.Liking for gherkins,35247,-0.0987105163918166,0.0583750770772546,-0.213125667463236,0.0157046346796023,0.0908940506160385
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20666.Liking for globe artichoke,35247,-0.0498969842341535,0.0601818533404874,-0.167853416781509,0.0680594483132018,0.407078594520798
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20667.Liking for goat's cheese,35247,-0.0264555136262493,0.0580955898642471,-0.140322869760174,0.087411842507675,0.648852933565768
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20668.Liking for going to a cafe,35247,-0.0299135131325159,0.0588398378367083,-0.145239595292464,0.0854125690274323,0.611199277419987
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20669.Liking for going to the gym,35247,-0.107221691241665,0.0596107087890382,-0.22405868046818,0.00961529798484932,0.0721162627254725
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20670.Liking for going to the pub,35247,-0.10444920724883,0.0608609019704663,-0.223736575110944,0.0148381606132841,0.0861775060527644
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20671.Liking for grapefruit,35247,0.0504519055495121,0.0578996998765747,-0.0630315062085744,0.163935317307599,0.383588240604454
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20672.Liking for green olives,35247,-0.0688854115745269,0.0593596697308328,-0.185230364246959,0.0474595410979054,0.245901309509847
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20673.Liking for haddock,35247,0.00781223979122708,0.0603789443900672,-0.110530491213305,0.126154970795759,0.897055879134582
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20674.Liking for ham,35247,-0.0263089906814897,0.059008381781511,-0.141965418973251,0.0893474376102719,0.655720302772843
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20675.Liking for hard cheese,35247,-0.0304042256303733,0.0598339224044397,-0.147678713543075,0.0868702622823284,0.611371174541492
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20676.Liking for herring,35247,-0.0309938002218938,0.0598111715472275,-0.14822369645446,0.086236096010672,0.604341772264176
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20677.Liking for honey,35247,-0.0673437561286244,0.0594278636045969,-0.183822368793634,0.0491348565363855,0.257174508865765
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35247,-0.120127928895053,0.0582799798640849,-0.234356689428659,-0.00589916836144623,0.0393246206452769
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20679.Liking for ice cream,35247,0.030186951058196,0.0583146949482372,-0.0841098510403489,0.144483753156741,0.604717256046509
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20680.Liking for jam,35247,0.014777325849131,0.0585861549942139,-0.100051537939528,0.12960618963779,0.800870020929412
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20681.Liking for kiwi fruit,35247,-0.00577343939009374,0.0582945155107776,-0.120030689791218,0.10848381101103,0.92111046844607
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20682.Liking for lager,35247,0.0138631470748459,0.0588912389913088,-0.101563681348119,0.129289975497811,0.813904292339694
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20683.Liking for lamb,35247,0.0044318377390946,0.059294773352947,-0.111785918032682,0.120649593510871,0.940422090596852
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20684.Liking for lemons,35247,-0.00599864070720382,0.0583010017883525,-0.120268604212375,0.108271322797967,0.918052998619179
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20685.Liking for lentils or beans,35247,-0.0343149181352935,0.0601565270274461,-0.152221711109088,0.0835918748385008,0.568409202982683
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20686.Liking for liver,35247,-0.029980469948744,0.0580697155135135,-0.14379711235523,0.0838361724577423,0.605674897491408
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20687.Liking for mackerel,35247,-0.0135944111816018,0.0592237790964696,-0.129673018210682,0.102484195847479,0.818454575565594
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20688.Liking for marzipan,35247,0.0503387956147759,0.0585702889083542,-0.0644589706455984,0.16513656187515,0.390121100165037
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20689.Liking for mayonnaise,35247,-0.11844739537359,0.0584971751345628,-0.233101858637333,-0.00379293210984638,0.0429277184385672
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20690.Liking for melon,35247,-0.0469663565157404,0.0614645876916297,-0.167436948391335,0.0735042353598539,0.444825216939908
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20691.Liking for milk chocolate,35247,0.0817960192199743,0.0586906010373394,-0.0332375588132109,0.196829597253159,0.163464972746782
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20692.Liking for mushrooms,35247,-0.034798762730558,0.061034674548942,-0.154426724846484,0.0848291993853683,0.568598901723344
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20694.Liking for orange juice,35247,0.0590568651498598,0.0587626017349518,-0.0561178342506457,0.174231564550365,0.314933392256344
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20695.Liking for oranges,35247,0.0721963034058552,0.0609819646874863,-0.0473283473816179,0.191720954193328,0.236500796303858
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20696.Liking for pasta,35247,-0.0357701630399747,0.0589624793196326,-0.151336622506455,0.0797962964265053,0.544099524006059
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20697.Liking for pears,35247,-0.0759522833106345,0.0605032882417681,-0.1945387282645,0.0426341616432311,0.209403379559748
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20698.Liking for pizza,35247,-0.0292353932529515,0.0586626028184071,-0.144214094777029,0.0857433082711264,0.618244873163943
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20699.Liking for plain yogurt,35247,0.0651005534810718,0.0604012344674061,-0.0532858660750441,0.183486973037188,0.281165272797642
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20700.Liking for plums,35247,0.0199808509944646,0.0595048433596789,-0.096648641990506,0.136610343979435,0.737044440051499
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20701.Liking for pollock,35247,-0.0625023179149062,0.0581800575302838,-0.176535230674262,0.0515305948444501,0.282735119329515
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20702.Liking for pork chop,35247,0.0217060709400916,0.0583813098322418,-0.0927212963311023,0.136133438211285,0.710056073490292
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20703.Liking for porridge,35247,-0.0336571257254325,0.0591456220069183,-0.149582544858992,0.0822682934081275,0.569339802488973
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20704.Liking for potato crisps,35247,0.0696550188731704,0.0605962776756396,-0.0491136853710833,0.188423723117424,0.250398086634687
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20705.Liking for potatoes,35247,0.0827243444882526,0.0592904309849596,-0.0334849002422681,0.198933589218773,0.162994918197922
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20706.Liking for prawns,35247,-0.0519555594286787,0.0592359275738975,-0.168057977473518,0.0641468586161604,0.380469685192643
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20707.Liking for raw carrots,35247,-0.0283785715056205,0.0600305409702032,-0.146038431807219,0.0892812887959778,0.636418921958556
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20708.Liking for red meat,35247,-0.0228396301418983,0.0589344628933257,-0.138351177412817,0.0926719171290201,0.698368009831697
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20709.Liking for red wine,35247,-0.117429805103628,0.0595058916838224,-0.23406135280392,-0.00079825740333582,0.0484938100815683
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35247,0.0113640181898153,0.0610535846073478,-0.108301007640586,0.131029044020217,0.852347592367794
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20711.Liking for roast chicken,35247,0.0698432564729248,0.0625315929080399,-0.0527186656268335,0.192405178572683,0.264069718899058
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20712.Liking for salad dressing,35247,-0.0248886612677206,0.0581710913024103,-0.138904000220445,0.0891266776850037,0.668773574684046
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20713.Liking for salad leaves,35247,-0.0765885635555155,0.0606174674150657,-0.195398799689044,0.0422216725780133,0.206467798147438
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20714.Liking for salami,35247,-0.0165385750962997,0.0578826479448367,-0.12998856506818,0.0969114148755803,0.775097812274006
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20715.Liking for salmon,35247,-0.00890049475212049,0.063155042053553,-0.132684377177084,0.114883387672843,0.887929254730352
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20716.Liking for salty foods,35247,-0.0921055508653704,0.0591533580351346,-0.208046132614234,0.0238350308834935,0.11950770244129
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20717.Liking for salty pretzels,35247,-0.0771843166532761,0.0596172041571122,-0.194034036801216,0.0396654034946637,0.195485224086926
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20718.Liking for sardines,35247,-0.0372433917469029,0.0583917471674378,-0.151691216195081,0.0772044327012752,0.523615382797217
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20719.Liking for sausages (meat),35247,0.00299749313918709,0.0579879094988817,-0.110658809478621,0.116653795756995,0.958776065695511
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20720.Liking for savoury biscuits,35247,-0.00565124075194943,0.0593683400971297,-0.122013187342324,0.110710705838425,0.924167490380885
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35247,-0.133322058488144,0.0585560868978884,-0.248091988808005,-0.0185521281682822,0.0228313793679381
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20722.Liking for skimmed milk,35247,0.118803623443699,0.0583372676032849,0.0044625789412603,0.233144667946137,0.0417440542004502
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20723.Liking for smoked fish,35247,0.0140863352368902,0.0585108688673049,-0.100594967743027,0.128767638216808,0.80975912211509
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20724.Liking for soft cheese,35247,-0.0795640199816158,0.0586578614880689,-0.194533428498231,0.0354053885349992,0.175019905457296
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20725.Liking for soy sauce,35247,-0.129098022240886,0.059144357345429,-0.245020962637927,-0.0131750818438455,0.0290917366465995
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20726.Liking for soya milk,35247,-0.0821896937133905,0.0590158751701753,-0.197860809046934,0.0334814216201531,0.163770550593089
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20727.Liking for spicy foods,35247,-0.101690444609879,0.0588702025990351,-0.217076041703987,0.01369515248423,0.0841528626765118
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20728.Liking for spinach,35247,0.0112426506679672,0.0590499801901819,-0.104495310504789,0.126980611840724,0.849008269567293
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20729.Liking for spirits,35247,-0.101089169578567,0.0595914374612684,-0.217888387002653,0.0157100478455193,0.0898671905317543
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20730.Liking for strawberries,35247,-0.00554603023078983,0.0634385249661371,-0.129885539164418,0.118793478702839,0.930337632096696
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35247,0.00876600553754863,0.0608600206055322,-0.110519634849295,0.128051645924392,0.8854772125729
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20732.Liking for sweet foods,35247,0.0269993135535721,0.0604057671241283,-0.0913959900097194,0.145394617116864,0.654915750531005
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20733.Liking for taking the stairs,35247,0.0393363756652578,0.0593819237801196,-0.0770521949437766,0.155724946274292,0.50772085547301
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20734.Liking for tea with sugar,35247,0.00238244165934048,0.0715748917585223,-0.137904346187363,0.142669229506044,0.973447619176121
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20735.Liking for tea without sugar,35247,0.0186719664699271,0.0613330591465197,-0.101540829457252,0.138884762397106,0.760806532743396
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20736.Liking for tomato ketchup,35247,0.0173497951928075,0.0580345261127677,-0.0963978759882171,0.131097466373832,0.76498356230963
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20737.Liking for tinned tuna,35247,0.0300841902787504,0.0593553523814302,-0.0862523003888528,0.146420680946354,0.612279389057175
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20738.Liking for turnip (white),35247,-0.0148514931742949,0.0584096185369282,-0.129334345506674,0.0996313591580844,0.799299863750931
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20739.Liking for vegetables,35247,-0.000839193306641547,0.0637960558110424,-0.125879462696285,0.124201076083002,0.9895051133364
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20740.Liking for vinegar,35247,0.0581052631707061,0.0587212069243928,-0.0569883024011037,0.173198828742516,0.322452943459417
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20741.Liking for watching television,35247,-0.117444124312247,0.0593488828881468,-0.233767934773015,-0.00112031385147959,0.0478752032375789
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20742.Liking for whisky,35247,-0.047686044888332,0.0615992927211915,-0.168420658621867,0.0730485688452033,0.438882427560475
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20743.Liking for white bread,35247,0.0596730413229581,0.0594546971234104,-0.0568581650389262,0.176204247684842,0.315576702112414
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20744.Liking for white rice,35247,0.0750796196800927,0.0596229034713228,-0.0417812711236999,0.191940510483885,0.207991834036374
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20745.Liking for white wine,35247,-0.0952897970280309,0.0582472210558211,-0.20945435029744,0.0188747562413785,0.101901201737052
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35247,-0.00291757438203377,0.0588878492591031,-0.118337758929876,0.112502610165808,0.960486939759022
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20747.Liking for whole milk,35247,0.0806987045011712,0.0584969312390799,-0.0339552807274254,0.195352689729768,0.167780159138497
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20748.Liking for wholemeal bread,35247,-0.00669365890269318,0.0606288460583641,-0.125526197177087,0.1121388793717,0.912092754074396
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20749.Liking for working up a sweat,35247,0.0375220016177235,0.0617578534101981,-0.0835233910662647,0.158567394301712,0.543497863903669
CCND2,G1/S-specific cyclin-D2,Physical measures,X21001.Body mass index (BMI),48888,-0.0120132677094179,0.0127213592811635,-0.0369471319004984,0.0129205964816625,0.345008348277174
CCND2,G1/S-specific cyclin-D2,Physical measures,X21002.Weight,48903,-0.00282129288084438,0.00682185139113523,-0.0161921216074694,0.0105495358457807,0.679195716270914
CCND2,G1/S-specific cyclin-D2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36000,-0.0023643457654518,0.00440723327545398,-0.0110025229853416,0.00627383145443799,0.591651716546981
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35064,-0.0413269930881378,0.0659443116460016,-0.170577843914301,0.0879238577380253,0.530883348099642
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35080,-0.0155308679618722,0.0676224222811058,-0.14807081563284,0.117009079709095,0.818355891286955
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35082,-0.0228209147271138,0.0661254825554345,-0.152426860535765,0.106785031081538,0.730020036929318
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21040.Satisfaction with bowel habits,35038,-0.0452110887712624,0.0610722799240346,-0.16491275742237,0.0744905798798454,0.459154918722551
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35021,0.0194248202229068,0.0664800060349183,-0.110875991605533,0.149725632051347,0.770151461996144
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21042.Greatest number of times bowels opened per day,35039,0.0300684242130511,0.065222874892934,-0.0977684105770995,0.157905259003202,0.644808293205421
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21043.Least number of times bowels opened per week,34986,0.134947481197246,0.0664533080152041,0.00469899748744643,0.265195964907046,0.042329890085114
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21044.Average number of times bowels opened per day,35008,0.0423951347896429,0.074774697615616,-0.104163272536964,0.18895354211625,0.57075535094027
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35083,0.0167077701372213,0.0669034628660229,-0.114423017080184,0.147838557354626,0.80280523398135
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35079,0.0144467183202801,0.0676207266227393,-0.118089905860289,0.146983342500849,0.830832596372159
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32305,-0.0240250914721896,0.115243240355278,-0.249901842568535,0.201851659624155,0.834873399363995
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35082,0.250312456259693,0.0761648459857381,0.101029358127647,0.39959555439174,0.00102050745652764
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35081,0.0229679972477259,0.100793282211015,-0.174586835885863,0.220522830381315,0.819753431045916
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35078,0.161031716818644,0.0768451591680446,0.010415204849277,0.311648228788012,0.036166100184715
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35078,0.134735319418886,0.189583621298944,-0.236848578327044,0.506319217164815,0.477304087337593
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35084,-0.00202418990010977,0.079103128329139,-0.157066321425222,0.153017941625003,0.979585825791294
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35081,0.0353007365808123,0.0720382144172634,-0.105894163677024,0.176495636838649,0.62413240389247
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34944,0.0014992331729768,0.0697988870687637,-0.1353065854818,0.138305051827754,0.982864039259299
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35077,0.0431584506420595,0.0670002978605353,-0.0881621331645897,0.174479034448709,0.519501266560082
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35080,-0.106364925526099,0.1077611949938,-0.317576867713946,0.104847016661749,0.323662172590371
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35085,0.0332825606206155,0.0670970659559303,-0.0982276886530079,0.164792809894239,0.619887516175855
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35084,0.0187759093794222,0.0669019014813415,-0.112351817524007,0.149903636282851,0.778989973563518
CCND2,G1/S-specific cyclin-D2,Working and living environment,X21100.Water hardness (USGS classification),48858,-0.0114837683474823,0.0355440452002342,-0.0811500969399414,0.0581825602449769,0.746633868754927
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2139.Age first had sexual intercourse,45653,-0.000575779275279896,0.00315102286884177,-0.00675178409820976,0.00560022554764997,0.855013902439091
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2149.Lifetime number of sexual partners,44620,-0.062569461457392,0.0398469585244977,-0.140669500165407,0.0155305772506236,0.116378786771865
CCND2,G1/S-specific cyclin-D2,Physical activities,X22032.IPAQ activity group,44605,0.0469606730201527,0.0401975801182308,-0.0318265840115796,0.125747930051885,0.242725514883917
CCND2,G1/S-specific cyclin-D2,Physical activities,X22033.Summed days activity,45033,0.00265871078285417,0.00307328896282365,-0.00336493558428018,0.00868235714998853,0.386995488748907
CCND2,G1/S-specific cyclin-D2,Physical activities,X22034.Summed minutes activity,44605,0.00226166429938133,0.00305215739457124,-0.0037205641939783,0.00824389279274097,0.458701617748601
CCND2,G1/S-specific cyclin-D2,Physical activities,X22037.MET minutes per week for walking,43771,0.00187593656044645,0.00326853395739057,-0.00453038999603906,0.00828226311693197,0.566018463907695
CCND2,G1/S-specific cyclin-D2,Physical activities,X22038.MET minutes per week for moderate activity,44605,0.00322872695568778,0.00296901018363315,-0.00259053300423319,0.00904798691560874,0.276843560904444
CCND2,G1/S-specific cyclin-D2,Physical activities,X22039.MET minutes per week for vigorous activity,44605,0.0169679891448977,0.0403131157512875,-0.0620457177276257,0.0959816960174211,0.673830375230929
CCND2,G1/S-specific cyclin-D2,Physical activities,X22040.Summed MET minutes per week for all activity,43771,0.00283790485134365,0.00317417935883465,-0.00338348669197227,0.00905929639465956,0.371304878326915
CCND2,G1/S-specific cyclin-D2,Eye measures,X2217.Age started wearing glasses or contact lenses,47272,-0.00575991017251045,0.00257103489813994,-0.0107991385728647,-0.000720681772156175,0.0250830296733383
CCND2,G1/S-specific cyclin-D2,Working and living environment,X22501.Year ended full time education,33412,0.0258486870716383,0.0129783465707911,0.00041112779288768,0.051286246350389,0.0464707795575577
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X22506.Tobacco smoking,33389,-0.0242186065738777,0.156880652859048,-0.331704686177612,0.283267473029857,0.87732071128453
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47856,0.148776509172014,0.135791405035508,-0.117374644697583,0.41492766304161,0.273256891661522
CCND2,G1/S-specific cyclin-D2,Physical measures,X23098.Weight,48483,-0.00107409724068174,0.00689814680025349,-0.0145944649691786,0.0124462704878151,0.876264751948231
CCND2,G1/S-specific cyclin-D2,Physical measures,X23099.Body fat percentage,48475,-0.0324581374628806,0.00658830558948769,-0.0453712164182765,-0.0195450585074847,8.43535558030137e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23100.Whole body fat mass,48461,-0.0234830804819577,0.0064967235529213,-0.0362166586456834,-0.0107495023182319,0.000301574025792064
CCND2,G1/S-specific cyclin-D2,Physical measures,X23101.Whole body fat-free mass,48482,0.018699868584949,0.00561774971299972,0.00768907914746959,0.0297106580224285,0.000874120574750741
CCND2,G1/S-specific cyclin-D2,Physical measures,X23102.Whole body water mass,48483,0.0184083361049017,0.00563503179554549,0.00736367378563255,0.0294529984241709,0.00108973138345991
CCND2,G1/S-specific cyclin-D2,Physical measures,X23104.Body mass index (BMI),48483,-0.00743869392464769,0.0126938305205931,-0.0323186017450101,0.0174412138957147,0.557876588357891
CCND2,G1/S-specific cyclin-D2,Physical measures,X23105.Basal metabolic rate,48483,0.0155045849428871,0.00599646178446527,0.00375151984533515,0.027257650040439,0.00972760337741104
CCND2,G1/S-specific cyclin-D2,Physical measures,X23106.Impedance of whole body,48480,-0.0248477760591585,0.00459313134183373,-0.0338503134891526,-0.0158452386291644,6.38579231874315e-08
CCND2,G1/S-specific cyclin-D2,Physical measures,X23107.Impedance of leg (right),48483,-0.0254873378206925,0.00372804674958125,-0.0327943094498718,-0.0181803661915133,8.34928714101011e-12
CCND2,G1/S-specific cyclin-D2,Physical measures,X23108.Impedance of leg (left),48483,-0.0219180836583355,0.00370389725631641,-0.0291777222807156,-0.0146584450359553,3.32251622456916e-09
CCND2,G1/S-specific cyclin-D2,Physical measures,X23109.Impedance of arm (right),48481,-0.0179087310262669,0.00453994409520339,-0.0268070214528656,-0.00901044059966828,8.01816244795697e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23110.Impedance of arm (left),48483,-0.0174084274614955,0.00455246857067161,-0.0263312658600118,-0.0084855890629791,0.000131741860781674
CCND2,G1/S-specific cyclin-D2,Physical measures,X23111.Leg fat percentage (right),48483,-0.0467484100399769,0.00777824885048608,-0.0619937777869296,-0.0315030422930241,1.88688178929438e-09
CCND2,G1/S-specific cyclin-D2,Physical measures,X23112.Leg fat mass (right),48483,-0.0415171607364749,0.00852251186296931,-0.0582212839878948,-0.0248130374850551,1.11649355199335e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23113.Leg fat-free mass (right),48482,0.0250203543448882,0.00572761730350974,0.0137942244300092,0.0362464842597673,1.25829903060317e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23114.Leg predicted mass (right),48482,0.0239509129589557,0.00576125649784358,0.0126588502231823,0.0352429756947291,3.23509461549217e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23115.Leg fat percentage (left),48480,-0.0404442985535613,0.00817182693083533,-0.0564610793379985,-0.0244275177691241,7.51336134359203e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23116.Leg fat mass (left),48480,-0.0312278195073602,0.00891317541324714,-0.0486976433173246,-0.0137579956973958,0.000460128109471923
CCND2,G1/S-specific cyclin-D2,Physical measures,X23117.Leg fat-free mass (left),48479,0.0202245651771437,0.00601670137295161,0.00843183048615854,0.0320172998681289,0.00077697831949933
CCND2,G1/S-specific cyclin-D2,Physical measures,X23118.Leg predicted mass (left),48479,0.0205634252070348,0.00605541501972117,0.00869481176838127,0.0324320386456883,0.000685478581582742
CCND2,G1/S-specific cyclin-D2,Physical measures,X23119.Arm fat percentage (right),48479,-0.0253966497153642,0.00738304255994474,-0.0398674131328559,-0.0109258862978725,0.000583241572877078
CCND2,G1/S-specific cyclin-D2,Physical measures,X23120.Arm fat mass (right),48477,-0.0215427425090546,0.00739592732315989,-0.036038760062448,-0.00704672495566124,0.00358632675782922
CCND2,G1/S-specific cyclin-D2,Physical measures,X23121.Arm fat-free mass (right),48478,0.0126867025495721,0.00574161235035685,0.00143314234287269,0.0239402627562715,0.0271442063081943
CCND2,G1/S-specific cyclin-D2,Physical measures,X23122.Arm predicted mass (right),48478,0.0148138922345858,0.00575354510114635,0.00353694383633898,0.0260908406328327,0.0100388847452651
CCND2,G1/S-specific cyclin-D2,Physical measures,X23123.Arm fat percentage (left),48477,-0.0265458037735942,0.00757437321129818,-0.0413915752677386,-0.0117000322794497,0.000458182193631455
CCND2,G1/S-specific cyclin-D2,Physical measures,X23124.Arm fat mass (left),48477,-0.0214159574614624,0.00739413493942059,-0.0359084619427268,-0.00692345298019807,0.00377962754115531
CCND2,G1/S-specific cyclin-D2,Physical measures,X23125.Arm fat-free mass (left),48477,0.0103145196022913,0.0058617766282464,-0.00117456258907165,0.0218036017936542,0.0784875281909902
CCND2,G1/S-specific cyclin-D2,Physical measures,X23126.Arm predicted mass (left),48475,0.0101290539589545,0.00586879271100717,-0.00137377975461956,0.0216318876725286,0.0843782180351679
CCND2,G1/S-specific cyclin-D2,Physical measures,X23127.Trunk fat percentage,48475,-0.0197669577682752,0.00470305772254319,-0.0289849509044599,-0.0105489646320906,2.64585123103093e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23128.Trunk fat mass,48475,-0.0168433050458098,0.00526681879891204,-0.0271662698916774,-0.00652034019994221,0.00138606098972068
CCND2,G1/S-specific cyclin-D2,Physical measures,X23129.Trunk fat-free mass,48474,0.0151121825054254,0.0050713659822907,0.00517230518013563,0.0250520598307152,0.00288698416497961
CCND2,G1/S-specific cyclin-D2,Physical measures,X23130.Trunk predicted mass,48471,0.015075804869199,0.00509521359586202,0.00508918622130945,0.0250624235170886,0.00309197586156329
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23400.Total Cholesterol,40302,0.0138843839811974,0.00368402101765256,0.00666370278659839,0.0211050651757964,0.000164874951286931
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40302,0.0113433092828183,0.00356531509017318,0.00435529170607891,0.0183313268595578,0.00146880802007069
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40302,0.0135065279718899,0.00355860895074179,0.00653165442843595,0.0204814015153438,0.000148158140993717
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23403.VLDL Cholesterol,40302,0.0103355919395686,0.00360994130817145,0.00326010697555261,0.0174110769035847,0.00420314609096269
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40302,0.0092813986538295,0.00356147201154899,0.00230091351119348,0.0162618837964655,0.00917134880537683
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23405.LDL Cholesterol,40302,0.0088062183284329,0.00357790838814182,0.00179351788767493,0.0158189187691909,0.0138594912096326
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23406.HDL Cholesterol,40302,0.0114596052608436,0.00413881274292223,0.003347532284716,0.0195716782369711,0.00563539219201876
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23407.Total Triglycerides,40302,0.00517201134170155,0.00389353540726684,-0.00245931805654146,0.0128033407399446,0.184086951183373
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23408.Triglycerides in VLDL,40302,0.00368622718590157,0.00387707586072435,-0.00391284150111815,0.0112852958729213,0.341739241779522
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23409.Triglycerides in LDL,40302,0.010534249002074,0.0038793716910612,0.00293068048759404,0.0181378175165539,0.0066287623277483
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23410.Triglycerides in HDL,40302,0.00861068402360169,0.00381446392826919,0.00113433472419408,0.0160870333230093,0.024003850513925
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40302,0.0161831195398875,0.00382524982737196,0.00868562987823849,0.0236806092015366,2.34934018712149e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23412.Phospholipids in VLDL,40302,0.00822706928035594,0.00372534138692701,0.000925400161978995,0.0155287383987329,0.0272362739816991
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23413.Phospholipids in LDL,40302,0.00874618723041989,0.00355679997732664,0.00177485927485968,0.0157175151859801,0.0139474236573927
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23414.Phospholipids in HDL,40302,0.0119970566136944,0.00409736970720602,0.00396621198757063,0.0200279012398182,0.00341853832376716
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23415.Total Esterified Cholesterol,40302,0.0136079457904622,0.00370405027407591,0.00634800725327339,0.0208678843276509,0.000240091662811731
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40302,0.0110960574418597,0.00356772426926059,0.00410331787410892,0.0180887970096104,0.00187483479286419
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40302,0.0086091216590926,0.00358186289153367,0.00158867039168661,0.0156295729264986,0.0162538347036754
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40302,0.0098033263591626,0.00411579088335173,0.00173637622779322,0.017870276490532,0.017241171911721
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23419.Total Free Cholesterol,40302,0.014281610422974,0.00363864936640602,0.00714985766481819,0.0214133631811298,8.72617693721537e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40302,0.00898368072936856,0.00368295056020661,0.0017650976313636,0.0162022638273735,0.0147328437745642
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23421.Free Cholesterol in LDL,40302,0.0089500891575142,0.00358499626663734,0.00192349647490502,0.0159766818401234,0.0125555004178684
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23422.Free Cholesterol in HDL,40302,0.0165511942197635,0.00417697782541708,0.00836431768194605,0.024738070757581,7.4638898792796e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40302,0.0141320185738664,0.00367680693647711,0.00692547697837122,0.0213385601693615,0.00012193941633702
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23424.Total Lipids in VLDL,40302,0.00683772701485478,0.00377391363184894,-0.00055914370356915,0.0142345977332787,0.0700379424185062
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23425.Total Lipids in LDL,40302,0.0092043717438297,0.00357587446128523,0.00219565779971065,0.0162130856879488,0.0100652899395525
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23426.Total Lipids in HDL,40302,0.01266752677031,0.00412521758762805,0.00458210029855901,0.0207529532420609,0.00214035031175404
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40302,0.00839211652467715,0.00389453972450102,0.000758818664655154,0.0160254143846992,0.0311956514303154
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23428.Concentration of VLDL Particles,40302,0.0102957109921687,0.00367450565397575,0.00309367991037625,0.0174977420739612,0.00508856690322491
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23429.Concentration of LDL Particles,40302,0.0097945225174973,0.00354051274371159,0.00285511753982259,0.016733927495172,0.00567702885761761
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23430.Concentration of HDL Particles,40302,0.00670775003579708,0.0039002855995409,-0.000936809739303085,0.0143523098108973,0.0854948460141204
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40302,-0.00394582945117121,0.00395533774289792,-0.0116982914272511,0.00380663252490872,0.318496990329171
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40302,0.00296902497831041,0.00375464745918942,-0.00439008404170085,0.0103281339983217,0.429100945393758
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40302,0.0174017392106147,0.00423825650700025,0.00909475645689421,0.0257087219643352,4.05675655386104e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23434.Phosphoglycerides,40291,0.0144560297951179,0.00390022176438251,0.00681159513692819,0.0221004644533076,0.000211195902331926
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40291,-0.00123900418929844,0.00405674604529022,-0.00919022643806727,0.00671221805947039,0.760053369019949
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23436.Total Cholines,40291,0.0152673330770238,0.00390695396991864,0.00760970329598325,0.0229249628580643,9.37194871471106e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23437.Phosphatidylcholines,40291,0.0156922720226566,0.00393696368089006,0.00797582320811206,0.0234087208372011,6.76603608927441e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23438.Sphingomyelins,40291,0.0126273203524249,0.00383101305660741,0.00511853476147438,0.0201361059433754,0.000983523124419028
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23439.Apolipoprotein B,40302,0.0111622042921357,0.00353974792908086,0.00422429835113722,0.0181001102331342,0.00161816033184538
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23440.Apolipoprotein A1,40302,0.01023845837832,0.00402570796317089,0.00234807077050509,0.018128845986135,0.0109955038143867
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40302,0.0054279470299587,0.00362197382068821,-0.0016711216585902,0.0125270157185076,0.134001760040025
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23442.Total Fatty Acids,40291,0.0113522083134573,0.00378489811686397,0.00393380800440388,0.0187706086225106,0.00271162602647125
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23443.Degree of Unsaturation,40291,-0.00295311116215182,0.00381307802333895,-0.0104267440878962,0.00452052176359252,0.438669925800692
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40291,0.000824288644707289,0.00379534011575638,-0.00661457798217521,0.00826315527158979,0.82806863862964
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40291,0.013554668116588,0.00373187598510529,0.00624019118578159,0.0208691450473943,0.000282355900023385
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40291,0.0118741016510868,0.0037867272307609,0.00445211627879548,0.0192960870233782,0.00171882687917168
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40291,0.00800749371650376,0.00386766433909849,0.000426871611870711,0.0155881158211368,0.0384408435507553
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23448.Saturated Fatty Acids,40291,0.0118910957577734,0.00378464334012317,0.00447319481113199,0.0193089967044148,0.00168277883990582
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23449.Linoleic Acid,40291,0.0145296722056755,0.00364997976637092,0.00737571186358848,0.0216836325477625,6.91346077416016e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23450.Docosahexaenoic Acid,40291,-0.000513557720366256,0.0037903595866883,-0.00794266251027532,0.00691554706954281,0.89222653139476
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40291,-0.00499473175264875,0.00373264598546182,-0.0123107178841539,0.00232125437885642,0.180884433894942
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40291,-0.00026324911261479,0.00404454360493098,-0.00819055457827951,0.00766405635304993,0.94810552878246
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40291,-0.00331696574732693,0.00398383063148132,-0.0111252737850303,0.00449134229037646,0.40508426031394
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40291,-0.00148551475190028,0.00404974238554494,-0.00942300982756837,0.0064519803237678,0.71376244655278
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40291,0.00700870028808138,0.00367016332067224,-0.000184819820436201,0.014202220396599,0.0562050017019906
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40291,0.00827950149274585,0.00387603820698343,0.000682466607058324,0.0158765363784334,0.0326952626042232
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40291,-0.00678397774569671,0.00372530415094319,-0.0140855738815454,0.000517618390151946,0.0686256568480024
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40291,-0.00051594206714102,0.00404774710096588,-0.00844952638503415,0.00741764225075211,0.898575468127136
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40291,0.00465865153357845,0.00370025147822376,-0.00259384136374012,0.011911144430897,0.208053406136517
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23460.Alanine,40296,-0.00423975976878225,0.00368387463841981,-0.0114601540600851,0.00298063452252058,0.249799454919918
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23461.Glutamine,40263,0.000351814685318513,0.00365909009724702,-0.00682000190528565,0.00752363127592268,0.923404663472041
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23462.Glycine,40287,0.00337447552803813,0.00389374825469717,-0.00425727105116833,0.0110062221072446,0.386158380305056
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23463.Histidine,40283,0.00127531016378394,0.00362497686500309,-0.00582964449162212,0.00838026481919,0.724985984157976
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40294,-0.000978241912431193,0.00382664854158459,-0.00847847305393698,0.0065219892290746,0.798234074329756
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23465.Isoleucine,40298,-0.00101151803569932,0.00372660135429205,-0.00831565669011174,0.00629262061871309,0.786064008730204
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23466.Leucine,40298,-0.00124119898275821,0.00376744871159959,-0.0086253984574934,0.00614300049197697,0.741819185856682
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23467.Valine,40294,-0.000369205829446395,0.00386924609221903,-0.00795292817019569,0.0072145165113029,0.92398246737933
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23468.Phenylalanine,40295,0.00651412379807401,0.00366126237824234,-0.000661950463280988,0.013690198059429,0.0752340742521408
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23469.Tyrosine,40285,0.00536617584481636,0.00372016048247371,-0.00192533870083211,0.0126576903904648,0.14920140484841
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23470.Glucose,40277,-0.00497245534493233,0.00363582900811584,-0.0120986802008394,0.00215376951097472,0.171456813614388
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23471.Lactate,40279,0.00273201921419995,0.00366321171539863,-0.00444787574798136,0.00991191417638126,0.45580472759994
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23472.Pyruvate,40265,-0.00111051110879609,0.00364285319503905,-0.00825050337107263,0.00602948115348044,0.760488781501043
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23473.Citrate,40299,0.00574663111937856,0.00365616193736726,-0.00141944627786128,0.0129127085166184,0.116033312334277
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23474.3-Hydroxybutyrate,40121,-0.00929545221348885,0.00385559419600313,-0.016852416837655,-0.00173848758932271,0.015929606762188
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23475.Acetate,40290,0.00518835526030263,0.00361524002432215,-0.00189751518736878,0.0122742257079741,0.151276992948899
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23476.Acetoacetate,40300,4.01328561798504e-05,0.00370431907671084,-0.00722033253417339,0.00730059824653309,0.991356025655928
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23477.Acetone,40300,-0.00718819507077022,0.00366878086778248,-0.0143790055716239,2.6154300834455e-06,0.0501041519480335
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23478.Creatinine,40039,0.016468555113572,0.00427523261055182,0.00808909919689046,0.0248480110302536,0.000117791009133085
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23479.Albumin,40299,0.00299254199550067,0.00366658024662891,-0.00419395528789199,0.0101790392788933,0.414422103831974
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23480.Glycoprotein Acetyls,40302,-0.0050363761044004,0.00390488328892087,-0.0126899473506853,0.00261719514188451,0.197159621433113
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40302,0.00564666126231046,0.00391727561334106,-0.00203119893983801,0.0133245214644589,0.149478263827059
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40302,0.00517806080727248,0.00386728924820786,-0.00240182611921492,0.0127579477337599,0.180618233427866
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40302,0.00341422869594392,0.00392552137053464,-0.00427979319030398,0.0111082505821918,0.384454931855761
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40302,0.00407050126578152,0.00388452321070598,-0.0035431642272022,0.0116841667587652,0.294718229399057
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40302,0.00460689042804273,0.00383325545303639,-0.00290629025990859,0.0121200711159941,0.229458152094847
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40302,0.00455904620625441,0.0039232623379545,-0.00313054797613641,0.0122486403886452,0.245238134224967
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40302,0.00693065913072797,0.00383049953122186,-0.000577119950466879,0.0144384382119228,0.0704259037157561
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40302,0.00301924627574788,0.00389713051259883,-0.00461912952894584,0.0106576220804416,0.4385123204026
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40302,0.00280160911931105,0.00387869399992465,-0.00480063112054126,0.0104038493591634,0.47012075095131
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40302,0.00383787937864428,0.0038674607443445,-0.00374234368027095,0.0114181024375595,0.321047842523245
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40302,0.00452626742406631,0.0037796511582784,-0.00288184884615936,0.011934383694292,0.231123351289477
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40302,0.00456180651280394,0.00371794738628716,-0.00272537036431889,0.0118489833899268,0.219860214126951
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40302,0.00451952479535623,0.00384049675071592,-0.00300784883604697,0.0120468984267594,0.239297625582621
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40302,0.00182744803278116,0.00390011334574635,-0.00581677412488169,0.00947167019044401,0.639391366543111
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40302,0.00346034085449314,0.00385043543024176,-0.00408651258878071,0.011007194297767,0.368838247945241
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40302,0.00267685719545641,0.00382763771290774,-0.00482531272184276,0.0101790271127556,0.484348172739288
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40302,0.00265654783666201,0.0038474241743475,-0.00488440354505908,0.0101974992183831,0.489910340196585
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40302,0.00472231648824745,0.00377244390974307,-0.00267167357484896,0.0121163065513439,0.210671891135357
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40302,0.00616592746421412,0.00370669065065114,-0.00109918621106211,0.0134310411394904,0.0962488254728187
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40302,0.00312341338827156,0.00383970125505431,-0.00440240107163489,0.010649227848178,0.415976283560077
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40302,0.00144911813400671,0.00381793055235932,-0.00603402574861755,0.00893226201663097,0.704282344528383
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40302,0.00896790923531059,0.00361263735681128,0.00188714001596049,0.0160486784546607,0.0130657611731672
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40302,0.0073552499554384,0.00365162871912759,0.000198057665948332,0.0145124422449285,0.0440085930019862
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40302,0.00931850187024257,0.00359782069456078,0.00226677330890345,0.0163702304315817,0.00960898933538215
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40302,0.0106161437744578,0.0035357282884952,0.00368611632900722,0.0175461712199084,0.00268337910987841
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40302,0.0104866768150934,0.00355003897543089,0.0035286004232489,0.017444753206938,0.00314381288768334
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40302,0.00999004100527998,0.00357294875829404,0.00298706143902365,0.0169930205715363,0.00518248456403919
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40302,0.00303467238970486,0.00378708206760765,-0.00438800846280614,0.0104573532422159,0.42296236533643
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40302,0.0067200744175725,0.00372865629978159,-0.000588091929999424,0.0140282407651444,0.0715288097876575
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40302,0.0073316166346337,0.00371773822493958,4.48497137521204e-05,0.0146183835555153,0.0486271032638934
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40302,0.0085766318878262,0.00363163861101855,0.00145862021022985,0.0156946435654226,0.0182113388280202
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40302,0.00890441906182023,0.00359520477341415,0.0018578177059285,0.015951020417712,0.0132732934071701
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40302,0.00855662167794556,0.00361204794169367,0.00147700771222596,0.0156362356436652,0.0178575309565171
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40302,0.00941606763989713,0.00357046072925158,0.00241796461056404,0.0164141706692302,0.00837065652856351
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40302,0.00361684595514127,0.00385789617208127,-0.00394463054213802,0.0111783224524206,0.348512705201872
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40302,0.0161811853338494,0.00363287187908701,0.00906075645083883,0.0233016142168599,8.50678612427115e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40302,0.0164252257565802,0.00366810866955139,0.00923573276425946,0.0236147187489009,7.61519124852584e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40302,0.0156056331353258,0.00367010164894689,0.00841223390338987,0.0227990323672617,2.13509218340463e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40302,0.0171917560852242,0.00362317023132949,0.0100903424318184,0.02429316973863,2.11159333507954e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40302,0.0172695010195207,0.00362960590968507,0.0101554734365379,0.0243835286025034,1.98028070624846e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40302,0.016250256659351,0.00363880546185315,0.00911819795411882,0.0233823153645832,8.05492772266767e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40302,0.00841877264672687,0.00386032318121969,0.000852539211536278,0.0159850060819175,0.0292156708947119
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23523.Concentration of IDL Particles,40302,0.0147864866509511,0.00352645182412717,0.00787464107566187,0.0216983322262404,2.77398551857173e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23524.Total Lipids in IDL,40302,0.0154460614676112,0.00363929942208806,0.00831303460031862,0.0225790883349038,2.21116758670488e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23525.Phospholipids in IDL,40302,0.0154902136128032,0.00364538186726365,0.00834526515296644,0.0226351620726399,2.16217773895138e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23526.Cholesterol in IDL,40302,0.0145475552496933,0.00363902918948758,0.00741505803829769,0.021680052461089,6.43889309514359e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40302,0.0142749111744907,0.00364373731686769,0.00713318603343,0.0214166363155514,8.99496221633721e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23528.Free Cholesterol in IDL,40302,0.0148731389643489,0.00362233563865911,0.00777336111257704,0.0219729168161208,4.05534369885915e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23529.Triglycerides in IDL,40302,0.0119964782101487,0.00386646689805486,0.00441820308996114,0.0195747533303362,0.00192246507416482
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40302,0.0101427560353621,0.00354187065069974,0.00320068955999058,0.0170848225107335,0.00419545539390357
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23531.Total Lipids in Large LDL,40302,0.0102498375466641,0.00359916173300376,0.00319548054997673,0.0173041945433515,0.00440978111538999
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23532.Phospholipids in Large LDL,40302,0.00968352763139375,0.00357376688378472,0.0026789445391757,0.0166881107236118,0.00674649588568628
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23533.Cholesterol in Large LDL,40302,0.00979202944506179,0.00360622608368359,0.00272382632104194,0.0168602325690816,0.00663156803802494
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40302,0.00939803325092974,0.00360531016746194,0.00233162532270434,0.0164644411791551,0.00915362560057423
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40302,0.0105821934342919,0.00361366443530555,0.003499411141093,0.0176649757274907,0.00341422094688475
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23536.Triglycerides in Large LDL,40302,0.0114548875322124,0.00387102044408116,0.00386768746181332,0.0190420876026115,0.00309150791333743
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40302,0.00799259802810274,0.00355979475792439,0.00101540030257094,0.0149697957536345,0.0247722382387055
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40302,0.00674880628391208,0.00358260890614928,-0.000273107172140508,0.0137707197399647,0.0596223751371354
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40302,0.00638021929736506,0.00357239778352092,-0.000621680358335957,0.0133821189530661,0.0741302956347773
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40302,0.00641611069657643,0.00357495643234745,-0.000590803910824577,0.0134230253039774,0.0727226074281981
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40302,0.00638886159726586,0.0035937148150097,-0.000654819440153156,0.0134325426346849,0.0754660986892594
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40302,0.00611073903996099,0.00356487969227153,-0.0008764251568912,0.0130979032368132,0.0865290513311472
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40302,0.00901093412851923,0.00388637264095379,0.0013936437522498,0.0166282245047887,0.0204349271270355
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40302,0.0102947992420927,0.00353694540984361,0.00336238623879919,0.0172272122453861,0.00361397905783055
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23545.Total Lipids in Small LDL,40302,0.00848253690561042,0.00354535233879065,0.00153364632158074,0.0154314274896401,0.0167469203287051
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23546.Phospholipids in Small LDL,40302,0.00879046210429644,0.00352002565929023,0.00189121181208758,0.0156897123965053,0.0125296446272133
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23547.Cholesterol in Small LDL,40302,0.00778112920742428,0.00354348816014956,0.000835892413531148,0.0147263660013174,0.0281200351011573
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40302,0.00828835536539396,0.00356618970578672,0.00129862354205199,0.0152780871887359,0.0201354661252774
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40302,0.0056832972145132,0.00353584269426912,-0.00124695446625427,0.0126135488952807,0.108008485225241
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23550.Triglycerides in Small LDL,40302,0.00831501877126905,0.00389867032426276,0.000673624935714043,0.0159564126068241,0.0329643717068474
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40302,0.022831839891947,0.00405538498756316,0.0148832853163232,0.0307803944675708,1.84576607693979e-08
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40302,0.0212645735864541,0.00407408009036817,0.0132793766093325,0.0292497705635757,1.82665332018637e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40302,0.0209057896462178,0.00409650087273745,0.0128766479356524,0.0289349313567832,3.39247816296766e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40302,0.0200343118582875,0.0040362806985724,0.0121232016890856,0.0279454220274894,7.02406547339745e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40302,0.0197033350798626,0.00408060881726469,0.0117053417980238,0.0277013283617014,1.39380193866153e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40302,0.0199048324266274,0.00385266854425496,0.0123536020798877,0.0274560627733672,2.4264763516834e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40302,0.0169676817742593,0.00380315139601396,0.00951350503807195,0.0244218585104467,8.21961720276107e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40302,0.0179800709574872,0.00425910338444492,0.00963222832397515,0.0263279135909992,2.44545490349426e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23559.Total Lipids in Large HDL,40302,0.0166943903424173,0.00426537950769702,0.00833424650733118,0.0250545341775035,9.13485515948854e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23560.Phospholipids in Large HDL,40302,0.0154958913367708,0.00426230675246214,0.00714177010194497,0.0238500125715965,0.000278626165122703
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23561.Cholesterol in Large HDL,40302,0.0163308831503193,0.00422469253658012,0.00805048577862225,0.0246112805220163,0.000111457040706001
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40302,0.0155471536076031,0.00421686217315254,0.00728210374822413,0.0238122034669821,0.000228083027567098
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40302,0.0186558048164166,0.00422832191283314,0.0103682938672636,0.0269433157655695,1.03334525012634e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23564.Triglycerides in Large HDL,40302,0.0164525068402704,0.00391837630218783,0.00877248928798221,0.0241325243925585,2.70416386960291e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40302,0.00790330443653743,0.00398842453790614,8.59923422414071e-05,0.0157206165308335,0.0475530673481587
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40302,0.0072703882857831,0.00395250987974896,-0.000476531078524859,0.0150173076500911,0.0658777791200671
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40302,0.00730122153583793,0.00392853657652411,-0.000398710154149323,0.0150011532258252,0.0631231643341637
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40302,0.00591212348669011,0.00398132759713944,-0.00189127860370319,0.0137155255770834,0.13758204793157
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40302,0.00482858458545455,0.00395934211346124,-0.00293172595692949,0.0125888951278386,0.222664382657341
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40302,0.0103154113422164,0.00405288099843735,0.00237176458527917,0.0182590580991536,0.0109347746665631
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40302,0.00737751333535828,0.00379446014983732,-5.96285583228662e-05,0.0148146552290394,0.0518862600290052
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40302,-0.00241596653057398,0.00364586467682293,-0.00956186129714692,0.00472992823599895,0.507562461274791
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23573.Total Lipids in Small HDL,40302,-0.000321445235869048,0.00367423031027587,-0.00752293664400976,0.00688004617227166,0.930286460679855
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23574.Phospholipids in Small HDL,40302,0.000758980247667613,0.00369722870386219,-0.00648758801190229,0.00800554850723751,0.837354354147189
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23575.Cholesterol in Small HDL,40302,-0.002590616778328,0.00364408741262981,-0.00973302810708244,0.00455179455042643,0.477155174038855
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40302,-0.00515923903675815,0.00361913112792778,-0.0122527360474966,0.00193425797398031,0.154027441414781
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40302,0.00602121838416397,0.0037479045094529,-0.00132467445436372,0.0133671112226917,0.108180230274604
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23578.Triglycerides in Small HDL,40302,0.00145748123769265,0.00386716281469634,-0.00612215787911217,0.00903712035449747,0.706265195994124
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39881,-0.010970875877479,0.00370901945356182,-0.0182405540064601,-0.00370119774849779,0.00310429688338697
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39881,-0.00795268335875432,0.00381798410484251,-0.0154359322042456,-0.000469434513262987,0.0372791776321604
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39881,-0.00772847085073625,0.00377104159613762,-0.015119712379166,-0.000337229322306523,0.040444831211399
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39881,-0.00931250196450491,0.00384038267768922,-0.0168396520127758,-0.00178535191623403,0.0153295296768555
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39881,0.010236074858814,0.00378768296619204,0.00281221624507757,0.0176599334725504,0.00689364633728673
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40206,0.00948007421243341,0.00368386597570308,0.00225969690005537,0.0167004515248114,0.0100833302294086
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40206,0.00270151668458497,0.00386667487614597,-0.00487716607266113,0.0102801994418311,0.4847751506829
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40206,0.00111303268091585,0.00387578310935575,-0.00648350221342141,0.00870956757525312,0.773982809093238
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40206,0.00983736058150439,0.00381002573167625,0.00236971014741894,0.0173050110155898,0.00983669425005658
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40206,-0.00428993660529826,0.00380201625594968,-0.0117418884669596,0.00316201525636311,0.259204315504792
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40301,0.00407067760110009,0.00379198037719635,-0.00336160393820477,0.0115029591404049,0.283071737000374
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40301,0.00474516056971357,0.00367217442758411,-0.00245230130835128,0.0119426224477784,0.196316965155043
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40301,0.00643777101114529,0.00377208901678354,-0.000955523461750436,0.013831065484041,0.0879084080387266
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40301,0.00219110989784792,0.00362000433781366,-0.00490409860426684,0.00928631839996269,0.545006495622571
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40301,-0.00457069301259547,0.00360798692477528,-0.011642347385155,0.00250096135996408,0.205243940954242
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40302,0.0127931613141186,0.00366977352285115,0.00560040520933034,0.0199859174189068,0.00049202893816676
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40302,0.00929089798654382,0.0038127202736161,0.00181796625025626,0.0167638297228314,0.0148328082327359
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40302,0.00849365205448731,0.00385232726346735,0.000943090618091304,0.0160442134908833,0.0274878063567651
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40302,0.0112389541932557,0.00371819571101124,0.00395129059967369,0.0185266177868378,0.00251109696841967
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40302,-0.0101933588060549,0.00377642409351814,-0.0175951500293504,-0.0027915675827593,0.00696096290866586
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40302,0.00674921576405612,0.00380826560042301,-0.000714984812772989,0.0142134163408852,0.0763797291236771
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40302,0.00649925143686573,0.00371077881329421,-0.000773875037190927,0.0137723779109224,0.0798956581101377
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40302,0.00556089827279905,0.00363973335645386,-0.00157297910585052,0.0126947756514486,0.126582920415635
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40302,0.00744236588016091,0.00382320658709778,-5.11190305507413e-05,0.0149358507908726,0.0516043708122106
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40302,-0.00662376149379051,0.00374341914611968,-0.0139608630201851,0.000713340032604053,0.0768476436738241
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40302,-0.0042497720046132,0.00373021943680283,-0.0115610021007467,0.00306145809152034,0.254610104807502
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40302,0.00978258187787374,0.00386037783059432,0.00221624132990887,0.0173489224258386,0.0112872901832676
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40302,0.0100862920944772,0.00389324155814237,0.00245553864051821,0.0177170455484363,0.00959010248983462
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40302,0.00539769615722546,0.00365762495209449,-0.00177124874887974,0.0125666410633307,0.140042583105148
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40302,-0.00962787081107498,0.00384250210501556,-0.0171591749369055,-0.00209656668524449,0.0122376954478915
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40302,-0.00491903733662981,0.0035213780295574,-0.0118209382745623,0.00198286360130269,0.162469469148563
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40302,0.00574380628038513,0.00373170480616332,-0.00157033513969497,0.0130579477004652,0.12378616928947
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40302,0.00366608621313042,0.0037344884619451,-0.00365351117228198,0.0109856835985428,0.326277109876526
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40302,0.00493577814095421,0.00357475997058436,-0.00207075140139115,0.0119423076832996,0.167389789892823
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40302,-0.00529274482964327,0.00384715227770898,-0.0128331632939529,0.00224767363466633,0.168924765496009
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40302,-0.0067056596378349,0.00356729113692201,-0.013697550266202,0.000286230990532235,0.0601666228680112
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40302,0.00341668291162522,0.00386591736361483,-0.00416051512105984,0.0109938809443103,0.37682538862622
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40302,-0.00233776978561925,0.00358364495511248,-0.00936171389763971,0.00468617432640121,0.514192689883376
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40302,0.00868351677705495,0.00385487528342504,0.00112796122154186,0.016239072332568,0.0243034128578359
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40302,-0.00129068387874469,0.00385491057477462,-0.00884630860530294,0.00626494084781357,0.737770576124589
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40302,-0.00560243503512229,0.00364047041758719,-0.0127377570535932,0.0015328869833486,0.123849474637741
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40302,0.00215573341293147,0.00355846164418776,-0.00481885140967654,0.00913031823553948,0.544656709743775
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40302,0.00158310694555311,0.00367690510716794,-0.00562362706449606,0.00878984095560228,0.666800900879972
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40302,0.000516002759118551,0.00393803652666946,-0.00720254883315359,0.0082345543513907,0.895753580092211
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40302,0.000830851295363863,0.00378477206954293,-0.00658730196094028,0.00824900455166801,0.826245304481496
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40302,-0.00127634113537661,0.00361054785007509,-0.00835301492152378,0.00580033265077056,0.723717748547371
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40302,0.000283102352432741,0.0036293819362538,-0.00683048624262471,0.00739669094749019,0.937827143181511
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40302,0.00343282298590821,0.00361349910877419,-0.00364963526728919,0.0105152812391056,0.342133085207415
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40302,-0.00372775586398401,0.00386070812270493,-0.0112947437844857,0.00383923205651765,0.334284054280054
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40302,0.00110741138737012,0.0038565206029282,-0.00645136899436914,0.00866619176910938,0.774000542765357
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40294,0.0156936949960349,0.00400059886318192,0.00785252122419838,0.0235348687678715,8.80398094728132e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40294,-0.0140315974253404,0.0037886798496441,-0.0214574099306428,-0.00660578492003798,0.00021362702722317
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40294,-0.00577268854907483,0.00369210189360685,-0.0130092082605443,0.0014638311623946,0.117957989748612
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40294,-0.0165287244688937,0.00420673280590693,-0.0247739207684713,-0.00828352816931609,8.57769085471331e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40294,-0.00534650065277722,0.00400566059285125,-0.0131975954147657,0.00250459410921122,0.181990040171664
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40302,-0.0139317994148138,0.00390650634819821,-0.0215885518572822,-0.00627504697234528,0.000363570283533422
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40302,0.00784925396960764,0.00404162435966333,-7.23297753324886e-05,0.0157708377145478,0.0521497826097272
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40302,0.00444935391115363,0.00406802097597863,-0.00352396720176449,0.0124226750240717,0.274093104426173
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40302,0.0177473784206668,0.00382609291266278,0.0102482363118477,0.0252465205294858,3.54934383776415e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40302,-0.000778577562314033,0.00400843530168583,-0.00863511075361826,0.00707795562899019,0.845995600181761
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40302,-0.00231174538299997,0.00397201338677793,-0.0100968916210847,0.00547340085508477,0.560572795880455
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40302,-0.00144607630623545,0.00393568379329219,-0.00916001654108815,0.00626786392861725,0.713307569333439
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40302,-0.00554582725131825,0.00390520141199965,-0.0132000220188376,0.00210836751620108,0.155602854462304
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40302,0.0152435097377451,0.00414910377734523,0.00711126633414845,0.0233757531413417,0.000239972726594192
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40302,0.00402819437201209,0.00387976030872218,-0.00357613583308338,0.0116325245771076,0.299172293041857
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40302,0.0069109186012022,0.00377400049275226,-0.00048612236459223,0.0143079595669966,0.0670986962075908
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40302,-0.00679550489322282,0.00377870774522146,-0.0142017720738569,0.000610762287411248,0.0721459422920293
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40302,-0.0115914733910903,0.00381435397319556,-0.0190676071785536,-0.00411533960362698,0.0023798886136897
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40302,0.0180144424769299,0.00378681802104417,0.0105922791556834,0.0254366057981765,1.98822234293118e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40302,0.00204152151092126,0.00391567885395175,-0.00563320904282418,0.00971625206466669,0.60211872378411
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48735,0.000893556159547803,0.00311161454994094,-0.00520520835833644,0.00699232067743204,0.773986724065498
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48735,0.000552993290175469,0.00303552983921908,-0.00539664519469392,0.00650263177504486,0.855448408190723
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47408,0.00748779945365956,0.00289194930510264,0.00181957881565839,0.0131560200916607,0.00962791564289111
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47408,-0.000565390925414387,0.00318752571047278,-0.00681294131794104,0.00568215946711226,0.859214940056264
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47408,-0.00126351200761722,0.00309117216025225,-0.00732220944171163,0.00479518542647718,0.68272903729899
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47408,0.00854273227776389,0.00283094181057653,0.00299408632903389,0.0140913782264939,0.00255112518030583
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24009.Traffic intensity on the nearest road,48735,-0.00387436061466041,0.0778202684427545,-0.156402086762459,0.148653365533138,0.960293424612897
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24010.Inverse distance to the nearest road,48735,-0.00559789710818803,0.0027321823578601,-0.0109529745295938,-0.000242819686782239,0.040487774551252
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24011.Traffic intensity on the nearest major road,48735,0.00788857752519262,0.00268194475275886,0.00263196580978525,0.0131451892406,0.00327152896730962
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24012.Inverse distance to the nearest major road,48735,-0.000541674385974533,0.00275691817066393,-0.00594523400047583,0.00486188522852676,0.844237918395473
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24013.Total traffic load on major roads,48735,0.00346279349794798,0.0547614843069923,-0.103869715743757,0.110795302739653,0.949580733329841
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24015.Sum of road length of major roads within 100m,48735,-0.0186883258025747,0.0531463790958461,-0.122855228830433,0.0854785772252838,0.725112999450801
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48735,0.000412403997166581,0.0030989874836664,-0.00566161147081956,0.00648641946515273,0.89413384481542
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48735,0.000780684073995333,0.00309232601696328,-0.00528027491925269,0.00684164306724336,0.800689321324048
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48735,0.00021954535960175,0.00305859730234996,-0.00577530535300417,0.00621439607220767,0.942777920420696
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48685,-0.000599248570783987,0.00304650868686824,-0.00657040559704574,0.00537190845547777,0.844064280769257
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24020.Average daytime sound level of noise pollution,48735,-0.00416543665552452,0.0027370704053611,-0.00953009465003227,0.00119922133898323,0.128060464562687
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24021.Average evening sound level of noise pollution,48735,-0.00413930318881488,0.00273780667294563,-0.00950540426778832,0.00122679789015856,0.130574240823043
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24022.Average night-time sound level of noise pollution,48735,-0.00417166084047988,0.0027369376719643,-0.0095360586775299,0.00119273699657015,0.12747307571179
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48735,-0.00414266430356954,0.00273730008966847,-0.00950777247931973,0.00122244387218065,0.13019107219977
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48735,-0.00416829161287524,0.00273732320781366,-0.00953344510019,0.00119686187443953,0.127834455441947
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2405.Number of children fathered,38423,-0.000124386195471093,0.0614860821768892,-0.120637107262174,0.120388334871232,0.998385926288627
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46639,-0.000385022007860209,0.00318292577140828,-0.00662355651982044,0.00585351250410003,0.903720301992618
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46639,0.000298079380358412,0.00286073863558261,-0.0053089683453835,0.00590512710610032,0.917014490789922
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24502.Water percentage, buffer 1000m",46639,-0.0039879085445023,0.00290335635685469,-0.00967848700393748,0.00170266991493289,0.169598713248009
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46639,-0.00111208795949317,0.00297377044219383,-0.00694067802619308,0.00471650210720674,0.708434426407981
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46639,0.00113058364337321,0.00287438336401596,-0.00450320775009807,0.00676437503684449,0.694079944441843
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24505.Water percentage, buffer 300m",46639,-0.00407809562733609,0.00293343408217502,-0.00982762642839913,0.00167143517372696,0.164482209464418
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48858,-0.00185033276067604,0.00304595440809623,-0.00782040340054465,0.00411973787919256,0.543544571611364
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48858,-0.00499577261638059,0.00285749230633068,-0.0105964575367887,0.000604912304027549,0.0804265583849379
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24508.Distance (Euclidean) to coast,48858,0.000142131161254803,0.00268772232694478,-0.00512580459955697,0.00541006692206657,0.957826751223874
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34649,0.00831909825231691,0.0732868837371684,-0.135323193872533,0.151961390377167,0.909627123396431
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2704.Years since last cervical smear test,37184,0.0484598974786489,0.0622825518542635,-0.0736139041557075,0.170533699113005,0.436553508687038
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2714.Age when periods started (menarche),39267,0.0343001910359449,0.0494188646479384,-0.0625607836740144,0.131161165745904,0.487653813998886
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2734.Number of live births,39580,-0.00329050139037603,0.0481263652748158,-0.097618177329015,0.0910371745482629,0.945490735794299
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2744.Birth weight of first child,38016,0.00647516762918893,0.0519066061322066,-0.095261780389936,0.108212115648314,0.900727085197522
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2754.Age at first live birth,36951,-0.00626086411307179,0.00489414122988696,-0.0158533809236502,0.00333165269750665,0.200844851597228
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2764.Age at last live birth,36928,0.0030985191324946,0.00448301302209273,-0.00568818639080715,0.0118852246557963,0.489480154033111
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2794.Age started oral contraceptive pill,35997,-0.00110882267141609,0.00705484684165753,-0.0149363224810649,0.0127186771382327,0.875114150053062
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2804.Age when last used oral contraceptive pill,35331,0.0131931100150318,0.0053301265143957,0.00274606204681623,0.0236401579832474,0.013343092056644
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2867.Age started smoking in former smokers,35222,0.000506209530568619,0.00524347935291743,-0.00977101000114954,0.0107834290622868,0.9230943046915
CCND2,G1/S-specific cyclin-D2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35096,-0.132094541276737,0.079764846898985,-0.288433641198748,0.0242445586452736,0.097764956386086
CCND2,G1/S-specific cyclin-D2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35094,-0.118045923423856,0.0871104644541113,-0.288782433753914,0.0526905869062026,0.175428331997074
CCND2,G1/S-specific cyclin-D2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35105,-0.0380405031090025,0.0920715858584812,-0.218500811391626,0.142419805173621,0.679502739463031
CCND2,G1/S-specific cyclin-D2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35082,0.0351329920926144,0.0906971097246898,-0.142633342967778,0.212899327153007,0.698499150186215
CCND2,G1/S-specific cyclin-D2,Mental health,X28739.Difficulty with standing for long periods,35108,-0.0336794854689591,0.069195103234212,-0.169301887808015,0.101942916870097,0.62646616300114
CCND2,G1/S-specific cyclin-D2,Mental health,X28740.Difficulty with taking care of household responsibilities,35130,0.0211681874999918,0.0774858498964958,-0.13070407829714,0.173040453297124,0.784718379619682
CCND2,G1/S-specific cyclin-D2,Mental health,X28741.Difficulty learning a new task,35075,0.100913330067264,0.0898223006712028,-0.0751383792482938,0.276965039382821,0.261280650961457
CCND2,G1/S-specific cyclin-D2,Mental health,X28742.Difficulty with joining in community activities,34850,0.0967648107181831,0.0964077158384821,-0.0921943123252418,0.285723933761608,0.315564265267049
CCND2,G1/S-specific cyclin-D2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35100,0.0667663867481685,0.0802513742705359,-0.0905263068220819,0.224059080318419,0.405461987799359
CCND2,G1/S-specific cyclin-D2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35131,0.0476823437128814,0.122970195169368,-0.19333923881908,0.288703926244843,0.698211042945289
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34826,-0.112807476615362,0.0699970851823161,-0.250001763572702,0.0243868103419773,0.107104502734585
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2897.Age stopped smoking,35218,0.00341370310831643,0.00495796410425146,-0.00630390653601642,0.0131313127526493,0.491146092169389
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34505,-0.0118700416366608,0.0120441398487344,-0.0354765557401802,0.0117364724668586,0.324401340717559
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34505,0.00968274336043977,0.0134595278201577,-0.0166979311670693,0.0360634178879488,0.471928023986199
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34505,0.0837935410459592,0.0448333877340827,-0.00407989891284291,0.171666981004761,0.0616780011359406
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34505,5.71291541496575e-05,0.0558667558506323,-0.10944171231309,0.109555970621389,0.999184124515276
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34505,0.00255895643978939,0.0652965907900979,-0.125422361508802,0.130540274388381,0.968740586343772
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34505,0.0188373428455951,0.0522031964750267,-0.0834809222454573,0.121155607936647,0.718228520800305
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34505,-0.00557822634300202,0.0221567010677582,-0.049005360435808,0.037848907749804,0.80123438945202
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34505,-0.0169278515310305,0.0382396517146273,-0.0918775688917001,0.0580218658296391,0.658016704490976
CCND2,G1/S-specific cyclin-D2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34476,-0.0160527024785518,0.0920290756028406,-0.196429690660119,0.164324285703016,0.861533621941443
CCND2,G1/S-specific cyclin-D2,Mental health,X29003.Recent feelings of depression,34466,0.0634434036065009,0.0906213041382826,-0.114174352504533,0.241061159717535,0.483899696697848
CCND2,G1/S-specific cyclin-D2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34479,0.0247651035223484,0.0702374510053977,-0.112900300448231,0.162430507492928,0.724409039822413
CCND2,G1/S-specific cyclin-D2,Mental health,X29005.Recent feelings of tiredness or low energy,34482,-0.0565551990604496,0.0693006099485021,-0.192384394559514,0.0792739964386144,0.414488206061969
CCND2,G1/S-specific cyclin-D2,Mental health,X29006.Recent poor appetite or overeating,34491,0.164848618169478,0.111207270317863,-0.0531176316535335,0.38281486799249,0.138305454541304
CCND2,G1/S-specific cyclin-D2,Mental health,X29007.Recent feelings of inadequacy,34463,0.0213512534678912,0.101794389222756,-0.178165749408711,0.220868256344494,0.83387182911787
CCND2,G1/S-specific cyclin-D2,Mental health,X29008.Recent trouble concentrating on things,34490,0.0970753815785263,0.0995718677382244,-0.0980854791883934,0.292236242345446,0.329640621685475
CCND2,G1/S-specific cyclin-D2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34484,0.415017055434051,0.177218963059709,0.0676678878370207,0.762366223031082,0.0192262654027983
CCND2,G1/S-specific cyclin-D2,Mental health,X29010.Recent thoughts of suicide or self-harm,34463,0.0482280806411499,0.190826083115948,-0.325791042266108,0.422247203548408,0.800484277426692
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#0.Substances taken for depression_None of options listed,35321,0.0288224232418853,0.023953257674066,-0.0181259617992841,0.0757708082830547,0.228915326905162
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35321,-0.0220233961416047,0.0590073225051545,-0.137677748251708,0.0936309559684982,0.708989006898281
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35321,0.00316701060432727,0.024399988614107,-0.0446569670793224,0.050990988287977,0.896732422941444
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35321,0.0196005311622585,0.0746128396260919,-0.126640634504882,0.165841696829399,0.792793353803542
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35321,-0.0236686640308699,0.0610342389793893,-0.143295772430473,0.0959584443687332,0.698182535035828
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35321,0.0490659041333742,0.0649790044658239,-0.0782929446196407,0.176424752886389,0.450215626549726
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35321,0.00885169334664915,0.0698565603748984,-0.128067164988152,0.14577055168145,0.899172178577015
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35321,-0.0473292286444602,0.06683185366875,-0.17831966183521,0.0836612045462898,0.478858133876546
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35321,0.0170845139190144,0.0423550360254345,-0.0659313566908373,0.100100384528866,0.686694243378365
CCND2,G1/S-specific cyclin-D2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35321,0.000858200870440107,0.0220167449725564,-0.0422946192757703,0.0440110210166506,0.96890803320258
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35321,0.0645182670789873,0.0381418332848888,-0.0102397261593949,0.139276260317369,0.0907854168534711
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35321,-0.0385330540044581,0.0610142692187341,-0.158121021673177,0.0810549136642608,0.52770996688219
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35321,-0.0504166808152899,0.0822210560926443,-0.211569950756873,0.110736589126293,0.539777083589687
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35321,-0.0648432115446255,0.0589329416696637,-0.180351777217166,0.0506653541279154,0.271249863172153
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35321,0.0223064427399936,0.0840836094602883,-0.142497431802171,0.187110317282159,0.790795890129282
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35321,-0.0597642086790111,0.0789647214701957,-0.214535062760595,0.0950066454025726,0.449170662155166
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35321,-0.0353335355256552,0.046753713644814,-0.126970814269491,0.0563037432181802,0.449835637188047
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35321,-0.050327923789157,0.0449017228591779,-0.138335300593146,0.0376794530148316,0.262397279676957
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35321,-0.127209114675035,0.0648914659822164,-0.254396388000179,-2.18413498907222e-05,0.0500017127726304
CCND2,G1/S-specific cyclin-D2,Mental health,X29058.Recent feelings or nervousness or anxiety,34402,-0.00849919092649107,0.0827971007166088,-0.170781508331044,0.153783126478062,0.918244054731506
CCND2,G1/S-specific cyclin-D2,Mental health,X29059.Recent inability to stop or control worrying,34414,-0.0199838423814306,0.0846633612300624,-0.185924030392353,0.145956345629492,0.813411788150426
CCND2,G1/S-specific cyclin-D2,Mental health,X29060.Recent worrying too much about different things,34412,-0.00381487656845271,0.0784212808068973,-0.157520586949971,0.149890833813066,0.961203324513617
CCND2,G1/S-specific cyclin-D2,Mental health,X29061.Recent trouble relaxing,34410,-0.0221500076054638,0.0846698082091013,-0.188102831695302,0.143802816484375,0.793636664052882
CCND2,G1/S-specific cyclin-D2,Mental health,X29062.Recent restlessness,34424,-0.0134250485697731,0.123879284596319,-0.256228446378559,0.229378349239013,0.913704752358663
CCND2,G1/S-specific cyclin-D2,Mental health,X29063.Recent easy annoyance or irritability,34395,0.0646296358700559,0.0874241203343849,-0.106721639985339,0.23598091172545,0.459779170616659
CCND2,G1/S-specific cyclin-D2,Mental health,X29064.Recent feelings of foreboding,34398,0.107462205478567,0.100216486202729,-0.0889621074787815,0.303886518435916,0.283634747492911
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35321,0.0318940938594845,0.0278413832638354,-0.0226750173376329,0.086463205056602,0.252020230675608
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35321,0.0262679259668328,0.0477392027270409,-0.0673009113781673,0.119836763311833,0.582176164768555
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35321,-0.0559104359411293,0.0596498494260768,-0.17282414081624,0.0610032689339813,0.348635758101146
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35321,0.0347108421561336,0.0570719840751572,-0.0771502466311745,0.146571930943442,0.543081312416944
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35321,0.0263157032525843,0.0423594841484128,-0.0567088856783049,0.109340292183473,0.534460218409716
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35321,-0.0274903671970497,0.0449821970552621,-0.115655473425363,0.060674739031264,0.541130348129748
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35321,0.0054304077904753,0.0455401492453179,-0.0838282847303478,0.0946891003112983,0.905085640502824
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35321,0.0402338027435415,0.04525248106559,-0.0484610601450149,0.128928665632098,0.373986359465939
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35321,-0.0559260231295714,0.0571615160769264,-0.167962594640347,0.0561105483812044,0.327922112247379
CCND2,G1/S-specific cyclin-D2,Mental health,X29076.Felt loved as a child,34396,-0.0528063706922697,0.0709961569859513,-0.191958838384734,0.0863460970001948,0.45703595781009
CCND2,G1/S-specific cyclin-D2,Mental health,X29077.Physically abused by family as a child,34417,0.280267275775644,0.110763856602074,0.0631701168355797,0.497364434715708,0.0114252208249038
CCND2,G1/S-specific cyclin-D2,Mental health,X29078.Felt hated by family member as a child,34402,0.108147122402985,0.109301025442983,-0.106082887465262,0.322377132271232,0.322492491743504
CCND2,G1/S-specific cyclin-D2,Mental health,X29079.Sexually molested as a child,34363,-0.0706979829293468,0.135301277015578,-0.33588848587988,0.194492520021187,0.601328880871095
CCND2,G1/S-specific cyclin-D2,Mental health,X29080.Someone to take to doctor when needed as a child,34382,0.0658761101175273,0.0966347996941387,-0.123528097282985,0.255280317518039,0.495458020919259
CCND2,G1/S-specific cyclin-D2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34408,0.102343973449549,0.16313626707204,-0.21740311001165,0.422091056910748,0.530455558493103
CCND2,G1/S-specific cyclin-D2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34376,-0.114553361061625,0.117439698536714,-0.344735170193585,0.115628448070336,0.329396112126851
CCND2,G1/S-specific cyclin-D2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34411,-0.0840682498172508,0.136225843779974,-0.351070903625999,0.182934403991497,0.537179817324553
CCND2,G1/S-specific cyclin-D2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34398,0.104234755474154,0.198925979400202,-0.285660164150241,0.494129675098549,0.60030945218684
CCND2,G1/S-specific cyclin-D2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34399,-0.105075740287793,0.172877701710884,-0.443916035641125,0.233764555065539,0.543344068599319
CCND2,G1/S-specific cyclin-D2,Mental health,X29086.Experienced a violent or sexual assault,34413,-0.149467926196174,0.160730384442013,-0.464499479702519,0.165563627310171,0.352450605228187
CCND2,G1/S-specific cyclin-D2,Mental health,X29087.Experienced a life-threatening injury or illness,34412,-0.000397563546996323,0.0802785739414328,-0.157743568472205,0.156948441378212,0.996048842134217
CCND2,G1/S-specific cyclin-D2,Mental health,X29088.Experienced a marital separation or divorce,34411,-0.0971569640036663,0.0800371160809155,-0.254029711522261,0.059715783514928,0.224841308039484
CCND2,G1/S-specific cyclin-D2,Mental health,X29089.Experienced the death of a spouse or partner,34421,0.0444191936254681,0.0887150679412576,-0.129462339539397,0.218300726790333,0.616606855966071
CCND2,G1/S-specific cyclin-D2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34409,0.00351165863675377,0.104373904488707,-0.201061194161112,0.20808451143462,0.973161536142625
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29091.Frequency of drinking alcohol,34408,-0.0672337714480179,0.0652055702102249,-0.195036689060059,0.0605691461640229,0.302539566157306
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33766,-0.0722654372126675,0.0799193356563845,-0.228907335099181,0.0843764606738461,0.365921285953709
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33788,0.0146164107973551,0.0826891919653537,-0.147454405454738,0.176687227049448,0.859702149113958
CCND2,G1/S-specific cyclin-D2,Mental health,X29104.Ever used cannabis,34409,-0.153542229342343,0.114079788270764,-0.377138614353041,0.0700541556683547,0.178386968677167
CCND2,G1/S-specific cyclin-D2,Mental health,X29108.Ever thought that life not worth living,34383,-0.0422833250209693,0.0880698619340827,-0.214900254411771,0.130333604369833,0.631168582810641
CCND2,G1/S-specific cyclin-D2,Mental health,X29109.Ever contemplated self-harm,34402,-0.121384704354354,0.129418245790699,-0.375044466104124,0.132275057395417,0.348326074157702
CCND2,G1/S-specific cyclin-D2,Mental health,X29111.Ever self-harmed,34409,-0.0526797920941909,0.238252439034287,-0.519654572601394,0.414294988413012,0.825016111065761
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34396,0.0895499772694419,0.138568109975733,-0.182043518282995,0.361143472821879,0.518144406110451
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35855,-0.188712448129525,0.0660145383377682,-0.318100943271551,-0.0593239529874995,0.00426768816187121
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35855,-0.0481374269895741,0.0485637465507374,-0.143322370229019,0.0470475162498712,0.321613466525009
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35855,-0.0682857748301485,0.0573362861865493,-0.180664895755785,0.0440933460954881,0.2337079499597
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35855,-0.197610674661502,0.0908508666523341,-0.375678373300077,-0.0195429760229269,0.0296568934780504
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34388,-0.0493177348254695,0.0753962943826975,-0.197094471815557,0.0984590021646176,0.513067642796509
CCND2,G1/S-specific cyclin-D2,Health and medical history,X29153.Pain or discomfort today,34400,-0.0123306836427104,0.0682891051787832,-0.146177329793125,0.121515962507705,0.856715357224219
CCND2,G1/S-specific cyclin-D2,Mental health,X29154.Anxiety or depression today,34400,0.016401332356905,0.0892546197744107,-0.15853772240094,0.19134038711475,0.85420974660546
CCND2,G1/S-specific cyclin-D2,Mental health,X29166.Frequency of confiding in someone close,34242,0.00670531928791135,0.066592721479275,-0.123816414811468,0.13722705338729,0.91979938158431
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34385,0.0298578324457313,0.0116025423720478,0.00711684939651753,0.052598815494945,0.0100983579248892
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34385,-0.00993853994684775,0.011870803802747,-0.0332053154002319,0.0133282355065364,0.402504354494238
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34385,-0.0202786555942041,0.0148028320807934,-0.0492922064725591,0.0087348952841509,0.170771970785174
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34385,-0.00717467641931998,0.0137753364146701,-0.0341743357920734,0.0198249829534335,0.602503980726953
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34385,-0.0594925525392361,0.0232205601635323,-0.105004850459759,-0.0139802546187128,0.0104332039547069
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34385,-0.00938358747331129,0.0112567196384665,-0.0314467579647057,0.0126795830180831,0.404545482031417
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34381,-0.000423273772501539,0.012056721990357,-0.0240544488736012,0.0232079013285982,0.971995874126878
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34381,0.0238407761869123,0.0185620774624979,-0.0125408956395836,0.0602224480134081,0.199066102046702
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34381,-0.0235815188144827,0.0268790448468405,-0.07626444671429,0.0291014090853246,0.380353580828391
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34381,-0.000813906096281546,0.0216158159382416,-0.0431809053352352,0.0415530931426721,0.969965585794256
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34381,-0.000476493880304837,0.0356260545520119,-0.0703035608022481,0.0693505730416384,0.989329229543832
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34381,-0.0105391365521408,0.0162781929839916,-0.0424443948007643,0.0213661216964827,0.517376531583038
CCND2,G1/S-specific cyclin-D2,Mental health,X29171.Frequency of feeling 'in tune' with people,34299,0.0726191472077741,0.0857813513068169,-0.0955123013535871,0.240750595769135,0.397279544654887
CCND2,G1/S-specific cyclin-D2,Mental health,X29172.Freuency of feeling that lacks companionship,34366,0.0400030559631255,0.0787520915082565,-0.114351043393057,0.194357155319308,0.611501783172509
CCND2,G1/S-specific cyclin-D2,Mental health,X29173.Frequency of feeling left out,34334,-0.0427065586852782,0.0830469467048878,-0.205478574226858,0.120065456856302,0.607102135317831
CCND2,G1/S-specific cyclin-D2,Mental health,X29174.Frequency of feeling isolated from others,34361,-0.0163982312918258,0.08579304423891,-0.184552598000089,0.151756135416438,0.848425714813489
CCND2,G1/S-specific cyclin-D2,Mental health,X29175.Tendency to bounce back quickly after hard times,34396,0.0416310378700458,0.068765992634724,-0.0931503076940132,0.176412383434105,0.544938652807371
CCND2,G1/S-specific cyclin-D2,Mental health,X29176.Ability to make it through stressful events,34396,0.0265313815736902,0.0653925108741605,-0.101637939739664,0.154700702887045,0.684961309951169
CCND2,G1/S-specific cyclin-D2,Mental health,X29177.Quick recovery from stressful events,34396,-0.0411852597861915,0.0678155090255611,-0.174103657476291,0.0917331379039082,0.543669544026883
CCND2,G1/S-specific cyclin-D2,Mental health,X29178.Hard to snap back when something bad happens,34396,-0.0297394851296963,0.0680056123399903,-0.163030485316077,0.103551515056685,0.66190523260262
CCND2,G1/S-specific cyclin-D2,Mental health,X29179.Comes through difficult times with little trouble,34396,-0.0325608774869972,0.0672549236680231,-0.164380527876322,0.099258772902328,0.628306076986833
CCND2,G1/S-specific cyclin-D2,Mental health,X29180.Tendency to take a long time to get over setbacks,34396,0.015614190582669,0.0662031633767466,-0.114144009635754,0.145372390801092,0.813556312692409
CCND2,G1/S-specific cyclin-D2,Mental health,X29181.General happiness,34372,0.0722343656518869,0.0687311056504475,-0.0624786014229902,0.206947332726764,0.293321214056318
CCND2,G1/S-specific cyclin-D2,Mental health,X29182.Belief that own life is meaningful,34285,-0.0644080103504332,0.0693189279961622,-0.200273109222911,0.0714570885220448,0.35285297839182
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34659,0.0185306059488555,0.0640422766479075,-0.106992256281043,0.144053468178754,0.772324849478438
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2946.Father's age,30023,-0.0290968243821434,0.0254736938444632,-0.0790252643172913,0.0208316155530045,0.25368810721859
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2966.Age high blood pressure diagnosed,35619,-0.0049739346924261,0.0052300868034857,-0.0152249048272581,0.00527703544240587,0.341628293558879
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48349,0.0062771391284173,0.00296342114837011,0.000468833677611876,0.0120854445792227,0.0341703902066625
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48350,-0.00444979382855621,0.00316790134648225,-0.0106588804676614,0.001759292810549,0.160141482089969
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30020.Haemoglobin concentration,48350,-0.00818067297448122,0.00342188744671478,-0.0148875723700422,-0.00147377357892026,0.0168263304971906
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30030.Haematocrit percentage,48350,-0.005018904203946,0.0033216095098879,-0.0115292588433263,0.00149145043543428,0.130808609566417
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30040.Mean corpuscular volume,48350,0.000495333432693233,0.00287504417521269,-0.00513975315072365,0.00613042001611011,0.863213533536044
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48350,-0.00362566380773248,0.00288259517431715,-0.0092755503493941,0.00202422273392915,0.208487509948462
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48350,-0.00685267802868179,0.00281638103870353,-0.0123727848645407,-0.00133257119282287,0.0149771767678565
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48350,0.00843461401359866,0.00289788592400092,0.00275475760255686,0.0141144704246405,0.00361140105715491
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30080.Platelet count,48350,-0.00294054213777602,0.00284936754946105,-0.00852530253471968,0.00264421825916763,0.302085996896064
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30090.Platelet crit,48350,-0.0031013161403251,0.00290713726118071,-0.0087993051722393,0.0025966728915891,0.286078382481949
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48350,0.000870647378858588,0.00271032087253413,-0.0044415815313083,0.00618287628902548,0.748036526944568
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30110.Platelet distribution width,48350,-0.00401224226388934,0.00282128432592269,-0.00954195954269782,0.00151747501491914,0.155003851854289
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30120.Lymphocyte count,48317,0.0147882175840015,0.00277943304552283,0.00934052881477675,0.0202359063532262,1.04597024322788e-07
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30130.Monocyte count,48317,0.0136590263683451,0.00285277724003762,0.00806758297787135,0.0192504697588188,1.69733117109413e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30140.Neutrophill count,48317,-0.00310847713494834,0.00293671165709679,-0.00886443198285804,0.00264747771296137,0.28984590983079
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30150.Eosinophill count,48317,0.0137339862345402,0.0027997292088913,0.00824651698511321,0.0192214554839671,9.39699296546865e-07
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30160.Basophill count,48317,0.150444276901541,0.038919098540121,0.074162843762904,0.226725710040178,0.000111198986187815
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30170.Nucleated red blood cell count,48317,0.0344596970630915,0.198909633159566,-0.355403183929657,0.42432257805584,0.862462277020914
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30180.Lymphocyte percentage,48318,0.0122402529813881,0.00277233757224808,0.00680647133978186,0.0176740346229943,1.01498679879984e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30190.Monocyte percentage,48318,0.00952061818787921,0.002821346622737,0.00399077880731469,0.0150504575684437,0.000740983470557012
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30200.Neutrophill percentage,48318,-0.0158242471154064,0.0027563992588332,-0.0212267896627194,-0.0104217045680933,9.55941275553509e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30210.Eosinophill percentage,48318,0.012126667553355,0.00278469981806947,0.00666865590993889,0.0175846791967712,1.3391221939968e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30220.Basophill percentage,48318,0.00791245971654825,0.00278397861089107,0.00245586163920175,0.0133690577938948,0.00448590912375782
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30230.Nucleated red blood cell percentage,48317,0.0331141021573066,0.198850041394851,-0.356631978976601,0.422860183291215,0.867743200951232
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30240.Reticulocyte percentage,47994,-0.00279022126419925,0.00301517831112638,-0.00869997075400696,0.00311952822560845,0.354774024300467
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30250.Reticulocyte count,47994,-0.00348839679135896,0.00307148223845336,-0.00950850197872755,0.00253170839600962,0.256081023945463
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30260.Mean reticulocyte volume,47994,-0.000796344877004544,0.00282221808597605,-0.0063278923255176,0.00473520257150851,0.77781637539533
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30270.Mean sphered cell volume,47994,-0.00177585809415136,0.00286345459552809,-0.00738822910138641,0.00383651291308369,0.535146615157662
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30280.Immature reticulocyte fraction,47994,-0.00109286355809077,0.00297446971968788,-0.00692282420867901,0.00473709709249748,0.713313929614418
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47994,-0.00202601440085545,0.00307312637635589,-0.008049342098513,0.00399731329680211,0.5097316535436
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30300.High light scatter reticulocyte count,47994,-0.00267564774630701,0.00311445403810848,-0.00877997766099963,0.00342868216838562,0.390292708468499
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30500.Microalbumin in urine,35957,0.00620514291662795,0.00481892744748442,-0.00323995488044151,0.0156502407136974,0.1979082012044
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48328,0.00186233864199878,0.00309752865006521,-0.00420881751212904,0.00793349479612659,0.54769145738984
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30520.Potassium in urine,48298,0.000760146468368128,0.0029059844133888,-0.00493558298187392,0.00645587591861018,0.793648332860066
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30530.Sodium in urine,48278,0.00706606740156989,0.00304927139286838,0.00108949547154787,0.0130426393315919,0.0204980865302071
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30600.Albumin,46420,-0.00263568822858564,0.00299637823144444,-0.00850858956221674,0.00323721310504546,0.379074937551943
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30610.Alkaline phosphatase,47966,0.0114820265087605,0.00296459607547442,0.00567141820083064,0.0172926348166904,0.000107846653625205
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30620.Alanine aminotransferase,47970,0.00987128704643748,0.00314255658897097,0.00371187613205439,0.0160306979608206,0.0016853878444479
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30630.Apolipoprotein A,46294,0.0101009598506585,0.00329842777118935,0.00363604141912739,0.0165658782821896,0.00219943214122436
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30640.Apolipoprotein B,47884,0.00279468335122302,0.00274462487452556,-0.00258478140284707,0.00817414810529312,0.308577697333185
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30650.Aspartate aminotransferase,47915,0.0236263884703441,0.00300000174559988,0.0177463850489683,0.0295063918917199,3.5793887616567e-15
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30660.Direct bilirubin,45227,-0.00749072944786223,0.00321341990004269,-0.0137890324519459,-0.00119242644377855,0.0197616265789866
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30670.Urea,47958,0.0103113735813787,0.0029523447988422,0.00452477777564804,0.0160979693871095,0.000479434691472416
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30680.Calcium,46416,-0.00871907582012759,0.00291152925412772,-0.0144256731582179,-0.00301247848203726,0.00275130312449594
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30690.Cholesterol,47974,0.0083921117075871,0.00277125804624674,0.00296044593694349,0.0138237774782307,0.00246293804087071
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30700.Creatinine,47966,0.0160595331523565,0.00333276924795624,0.00952730542636226,0.0225917608783507,1.45643536397814e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30710.C-reactive protein,47916,0.00255769345445876,0.00313689959836068,-0.00359062975832818,0.0087060166672457,0.414878287999767
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30720.Cystatin C,47981,0.0125231135051813,0.00325586323508136,0.00614162156442184,0.0189046054459408,0.000120297749334586
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30730.Gamma glutamyltransferase,47968,-0.00030106138904927,0.00317383949775164,-0.00652178680464248,0.00591966402654394,0.924429299736534
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30740.Glucose,46403,-0.000684757333349399,0.002982998509967,-0.00653143441288472,0.00516191974618592,0.818441579819987
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47966,0.0166910160713388,0.00305050453387849,0.0107120271849369,0.0226700049577406,4.51799382231088e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30760.HDL cholesterol,46409,0.0147716584225339,0.00337401002611263,0.00815859877135317,0.0213847180737147,1.20439689329127e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30770.IGF-1,47864,-0.0107512302746233,0.00290708438456721,-0.016449115668375,-0.00505334488087157,0.000217682028959742
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30780.LDL direct,47930,0.00536097583877278,0.00271690217368256,3.58475783549684e-05,0.0106861040991906,0.0484881052008265
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30790.Lipoprotein A,44159,0.00434347224482341,0.00313019328522961,-0.00179170659422661,0.0104786510838734,0.165277980891068
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30810.Phosphate,46385,0.00138138366922061,0.00311133359554383,-0.0047168301780453,0.00747959751648652,0.657059430042955
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30830.SHBG,46266,0.00258627461712502,0.0036060902275359,-0.00448166222884535,0.00965421146309538,0.473262785896042
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30840.Total bilirubin,47899,-0.00707904863200642,0.00305666511029483,-0.0130701122481843,-0.00108798501582856,0.0205723801190172
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30850.Testosterone,45754,-0.00135371332887436,0.00478900658919136,-0.0107401662436894,0.0080327395859407,0.777432573936591
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30860.Total protein,46402,-0.00475285581256165,0.00291781205492661,-0.0104717674402178,0.000966055815094498,0.103350190677714
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30870.Triglycerides,47963,-0.00155077610397541,0.0031679091783233,-0.00775987809348909,0.00465832588553826,0.624474582335162
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30880.Urate,47942,0.00906379226228976,0.00344184749915944,0.00231777116393725,0.0158098133606423,0.00846018494252788
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30890.Vitamin D,47019,0.00164847423904608,0.00321523630371262,-0.00465338891623066,0.00795033739432282,0.608162628299891
CCND2,G1/S-specific cyclin-D2,Physical measures,X3137.Number of measurements made,46754,0.0447096825678985,0.0458433095372221,-0.0451432041250568,0.134562569260854,0.329438938311922
CCND2,G1/S-specific cyclin-D2,Physical measures,X3143.Ankle spacing width,40308,0.00291716254180291,0.00496927382214868,-0.0068226141496085,0.0126569392332143,0.557188761956981
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40308,0.00421009471512606,0.00387254321212968,-0.00338008998064811,0.0118002794109002,0.276987327092146
CCND2,G1/S-specific cyclin-D2,Physical measures,X3146.Speed of sound through heel,40308,0.00397743466754822,0.00372088016968047,-0.00331549046502549,0.0112703598001219,0.285115438935543
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40308,0.00415940441089005,0.00376580455802175,-0.00322157252283259,0.0115403813446127,0.269391778981324
CCND2,G1/S-specific cyclin-D2,Physical measures,X3148.Heel bone mineral density (BMD),40297,0.00441964933438517,0.00377518906861599,-0.00297972124010218,0.0118190199088725,0.241740730574324
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3526.Mother's age at death,45544,-0.00143929530274697,0.00290702685458684,-0.00713706793773718,0.00425847733224323,0.620529799693155
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3581.Age at menopause (last menstrual period),37194,-0.00649336316609889,0.00401805194490942,-0.0143687449781214,0.00138201864592357,0.106123449877371
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32289,0.00385794537319771,0.00606481120992972,-0.00802908459826454,0.01574497534466,0.524745497750917
CCND2,G1/S-specific cyclin-D2,Physical measures,X4100.Ankle spacing width (left),35728,-0.00352276620238083,0.00621731763412647,-0.0157087087652687,0.00866317636050705,0.571001716758264
CCND2,G1/S-specific cyclin-D2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35725,0.00309323393837501,0.00486363900598153,-0.00643949851334878,0.0126259663900988,0.524804131034644
CCND2,G1/S-specific cyclin-D2,Physical measures,X4103.Speed of sound through heel (left),35728,0.00493026633166424,0.0046555270376351,-0.00419456666210054,0.014055099325429,0.289632744329407
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35728,0.00444665971441667,0.00471601396471319,-0.00479672765642117,0.0136900470852545,0.345774492280449
CCND2,G1/S-specific cyclin-D2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35726,0.00422774892403818,0.00470580255884714,-0.0049956240913022,0.0134511219393786,0.36899911966417
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35728,0.00444440102029557,0.00471600323462983,-0.0047989653195789,0.01368776736017,0.346018434708327
CCND2,G1/S-specific cyclin-D2,Physical measures,X4119.Ankle spacing width (right),35725,-0.00208598730155562,0.00616131498479087,-0.0141621646717457,0.0099901900686345,0.734950574956321
CCND2,G1/S-specific cyclin-D2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35724,-0.00175760780995454,0.00481910444011486,-0.0112030525125797,0.00768783689267057,0.715334710756719
CCND2,G1/S-specific cyclin-D2,Physical measures,X4122.Speed of sound through heel (right),35725,-0.000458189551562815,0.0046208172844737,-0.00951499142913126,0.00859861232600563,0.921016113743017
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35725,-0.000528837484706157,0.00468116706234932,-0.00970392492691083,0.00864624995749852,0.910056788362138
CCND2,G1/S-specific cyclin-D2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35721,-0.00021317444581458,0.00467767143711453,-0.00938141046255906,0.0089550615709299,0.963652166952928
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35725,-0.000530916500197934,0.00468117115667566,-0.00970601196728223,0.00864417896688636,0.909704784575985
CCND2,G1/S-specific cyclin-D2,Physical measures,X4194.Pulse rate,36032,-0.00266433297987357,0.00446258333863914,-0.0114109963236063,0.00608233036385914,0.550501605653231
CCND2,G1/S-specific cyclin-D2,Physical measures,X4195.Pulse wave reflection index,36032,-0.00303590545138635,0.00478855604776665,-0.012421475305009,0.00634966440223629,0.526107355291586
CCND2,G1/S-specific cyclin-D2,Physical measures,X4196.Pulse wave peak to peak time,36026,0.000921397422958728,0.00439241340126736,-0.00768773284352529,0.00953052768944275,0.833853289957423
CCND2,G1/S-specific cyclin-D2,Physical measures,X4198.Position of the pulse wave peak,36032,0.00492014813019452,0.00466901870417342,-0.00423112852998538,0.0140714247903744,0.292017982275861
CCND2,G1/S-specific cyclin-D2,Physical measures,X4199.Position of pulse wave notch,36032,0.000253289102144874,0.00446907511637347,-0.00850609812594713,0.00901267633023688,0.954804983912992
CCND2,G1/S-specific cyclin-D2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36032,0.00605496895124111,0.00460302736556868,-0.0029669646852735,0.0150769025877557,0.188408900584624
CCND2,G1/S-specific cyclin-D2,Physical measures,X4269.Number of triplets attempted (left),35874,-0.10908404184948,0.181720500927149,-0.465256223666693,0.247088139967732,0.548336899755283
CCND2,G1/S-specific cyclin-D2,Physical measures,X4270.Volume level set by participant (left),35798,-0.0172079872071505,0.0616374474095087,-0.138017384129788,0.103601409715487,0.780114881765275
CCND2,G1/S-specific cyclin-D2,Physical measures,X4276.Number of triplets attempted (right),35870,-0.0387143569452059,0.175537867381327,-0.382768577012607,0.305339863122195,0.82545189921334
CCND2,G1/S-specific cyclin-D2,Physical measures,X4277.Volume level set by participant (right),35791,-0.0563302780013725,0.0616181991681643,-0.177101948370974,0.0644413923682294,0.360654395354562
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4288.Time to answer,36039,-0.00263679854440044,0.00530577370454557,-0.0130361150053098,0.00776251791650887,0.619227737911916
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4290.Duration screen displayed,36039,0.00239672118083552,0.00492957931727177,-0.00726525428101716,0.0120586966426882,0.626846728858168
CCND2,G1/S-specific cyclin-D2,Physical measures,X46.Hand grip strength (left),48853,0.00744774425473254,0.00400319080739925,-0.000398509727769981,0.0152939982372351,0.0628365275114149
CCND2,G1/S-specific cyclin-D2,Physical measures,X47.Hand grip strength (right),48871,0.00677614532443346,0.00396924135163835,-0.0010035677247777,0.0145558583736446,0.0878073795132831
CCND2,G1/S-specific cyclin-D2,Physical measures,X48.Waist circumference,48932,-0.0240964766677323,0.0060423414387873,-0.0359394658877554,-0.0122534874477091,6.68904909851118e-05
CCND2,G1/S-specific cyclin-D2,Health and medical history,X4803.Tinnitus,35950,0.0819067650067476,0.0690151793042302,-0.0533629864295436,0.217176516443039,0.235350838278996
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4825.Noisy workplace,36024,-0.000591692599250817,0.0795509921412055,-0.156511637196014,0.155328251997512,0.994065683678504
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4836.Loud music exposure frequency,35984,-0.0519675400848031,0.133093287695618,-0.312830383968215,0.208895303798609,0.696209041705992
CCND2,G1/S-specific cyclin-D2,Physical measures,X49.Hip circumference,48927,-0.000518630398949675,0.00491226434778844,-0.010146668520615,0.00910940772271567,0.915917712073083
CCND2,G1/S-specific cyclin-D2,Physical measures,X50.Standing height,48913,0.0001415700119563,0.00389141140006753,-0.00748559633217606,0.00776873635608866,0.9709796342356
CCND2,G1/S-specific cyclin-D2,Health and medical history,X5057.Number of older siblings,34968,0.00339521979029224,0.0672373833718933,-0.128390051618619,0.135180491199203,0.959728873395743
CCND2,G1/S-specific cyclin-D2,Physical measures,X51.Seated height,48837,-0.0035706877953165,0.00364962346033319,-0.0107239497775696,0.00358257418693655,0.327902638385173
CCND2,G1/S-specific cyclin-D2,Eye measures,X5181.Ever had eye surgery,33809,-0.135908712252666,0.137895329988488,-0.406183559030102,0.134366134524771,0.324384421297055
CCND2,G1/S-specific cyclin-D2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33796,-0.00112268392344111,0.00533258955064638,-0.011574559442708,0.0093291915958258,0.83326133424364
CCND2,G1/S-specific cyclin-D2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33795,-0.00524074848531604,0.00550469960790188,-0.0160299597168037,0.00554846274617164,0.341121706338971
CCND2,G1/S-specific cyclin-D2,Eye measures,X5190.Duration at which refractometer first shown (right),33734,-0.00560005835356004,0.00565702480981949,-0.0166878269808062,0.00548771027368616,0.322261108814106
CCND2,G1/S-specific cyclin-D2,Eye measures,X5193.Duration at which refractometer first shown (left),33732,-0.00406464410284847,0.00571961310033678,-0.0152750857795086,0.00714579757381162,0.477337556808672
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5199.logMAR, initial (right)",33781,-0.130604964828089,0.0794812524656575,-0.286388219660778,0.0251782900045993,0.100406544760085
CCND2,G1/S-specific cyclin-D2,Eye measures,X5200.Final number of letters displayed (right),33781,-0.199494848102753,0.474552442123813,-1.12961763466543,0.730627938459921,0.674223740265737
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5201.logMAR, final (right)",33727,0.000258488252606781,0.0058915044395023,-0.0112888604488177,0.0118058369540313,0.96500617927346
CCND2,G1/S-specific cyclin-D2,Eye measures,X5202.Number of rounds to result (right),33781,-0.168867075924811,0.0724997788849016,-0.310966642539218,-0.0267675093104038,0.0198913494631091
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5206.logMAR, initial (left)",33777,0.0376365864877463,0.0787660962031083,-0.116744962070346,0.192018135045839,0.63279596389649
CCND2,G1/S-specific cyclin-D2,Eye measures,X5207.Final number of letters displayed (left),33777,0.219374366683523,0.42704954853021,-0.617642748435689,1.05639148180273,0.607488142369061
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5208.logMAR, final (left)",33728,0.000481706828599694,0.00586783971457351,-0.0110192590119644,0.0119826726691638,0.934576618572016
CCND2,G1/S-specific cyclin-D2,Eye measures,X5209.Number of rounds to result (left),33775,-0.0109777580505158,0.0730159398546838,-0.154089000165696,0.132133484064665,0.88049715883663
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33568,0.00554187765700602,0.005531221618916,-0.00529931671606933,0.0163830720300814,0.316434504057006
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33568,0.00885849454869851,0.00557982953185785,-0.00207797133374287,0.0197949604311399,0.112450834051446
CCND2,G1/S-specific cyclin-D2,Eye measures,X5256.Corneal hysteresis (right),33568,0.00291286014665944,0.00556716628414897,-0.00799878577027253,0.0138245060635914,0.600846743796557
CCND2,G1/S-specific cyclin-D2,Eye measures,X5257.Corneal resistance factor (right),33568,0.00805760687057196,0.0056123741495245,-0.00294264646249607,0.01905786020364,0.151163223583554
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33556,0.0102259371886617,0.00556341366417532,-0.000678353593121923,0.0211302279704453,0.0661202268289844
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33556,0.00936926769286713,0.00557737775416486,-0.001562392705296,0.0203009280910303,0.0930542865619768
CCND2,G1/S-specific cyclin-D2,Eye measures,X5264.Corneal hysteresis (left),33556,-0.00547546970681791,0.00565921051086664,-0.0165675223081165,0.00561658289448072,0.3333315769785
CCND2,G1/S-specific cyclin-D2,Eye measures,X5265.Corneal resistance factor (left),33556,0.000633768710473907,0.0056636925816137,-0.0104670687494889,0.0117346061704367,0.910907633832709
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33882,0.588084655403109,0.446719745134468,-0.287486045060448,1.46365535586667,0.18808708474864
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48884,0.00601121031384945,0.0147410859671691,-0.022881318181802,0.0349037388095009,0.683435135187648
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48884,-0.0068595603112687,0.0157964335736214,-0.0378205701155667,0.0241014494930293,0.66411354943693
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48884,0.00896505386267037,0.0418842427750015,-0.0731280619763326,0.0910581697016733,0.830515277995514
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48884,-0.00853528814410344,0.00634726293447636,-0.0209759234956771,0.00390534720747022,0.178731329354783
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48884,0.00408085392243737,0.00598065348786175,-0.00764122691377165,0.0158029347586464,0.495030445762236
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36931,-0.0124398662964107,0.0085159849099375,-0.0291311967198882,0.00425146412706684,0.144120112110809
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36931,-0.00994442647021708,0.0179078245609251,-0.0450437626096303,0.0251549096691961,0.578697457017056
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36931,0.0148527183392673,0.0222259100722308,-0.028710065402305,0.0584155020808396,0.503986666948869
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36931,0.0223613449519139,0.0121126549900772,-0.0013794588286373,0.0461021487324652,0.0649137921150487
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48948,0.000377891533817386,0.0123119693486411,-0.0237535683895191,0.0245093514571539,0.975514667048679
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48948,0.000377891533817386,0.0123119693486411,-0.0237535683895191,0.0245093514571539,0.975514667048679
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48948,-0.00947944801592882,0.00992169406712251,-0.0289259683874889,0.0099670723556313,0.33937382215684
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48948,0.00940766728475509,0.0168312824668048,-0.0235816463501822,0.0423969809196924,0.576209400134643
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48948,-0.021917653336363,0.041494990955082,-0.103247835608324,0.0594125289355977,0.597366477648879
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48948,0.0060640169998844,0.0276541997533376,-0.0481382145166572,0.060266248516426,0.826434091180861
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48948,0.11090934333264,0.0451117613773622,0.02249029103301,0.19932839563227,0.0139586044940896
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48884,-0.0128126404081875,0.00914681989498058,-0.0307404074023494,0.00511512658597448,0.161297002453455
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48884,-0.0120683072091442,0.0154175036524109,-0.0422866143678697,0.0181499999495812,0.433773587146207
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48884,-0.0121679240673342,0.00915436253255866,-0.0301104746311491,0.00577462649648083,0.183799363466473
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48884,-0.0201117579019567,0.0128837606727511,-0.0453639288205488,0.00514041301663537,0.118536022311924
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48884,-0.0346318385464823,0.0156446741350704,-0.0652953998512204,-0.00396827724174424,0.0268642573799601
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48884,-0.00264491658861482,0.00614398813623099,-0.0146871333356276,0.00939730015839793,0.666845000487713
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37338,0.0205268413333201,0.0143710003103472,-0.00764031927496043,0.0486940019416007,0.153229029917525
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37338,0.010879019788544,0.0122838795164341,-0.0131973840636668,0.0349554236407548,0.375841000917422
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37338,0.000728191998577845,0.0176053509325411,-0.0337782958292027,0.0352346798263584,0.967008344242643
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37338,0.000419864674034316,0.0138031471008271,-0.0266343036435869,0.0274740329916555,0.975734403417137
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48871,-0.0196010431342286,0.0211419667526132,-0.0610392979693504,0.0218372117008933,0.353877988239407
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48871,0.0499633845617584,0.0330195008350097,-0.0147548370748606,0.114681606198377,0.130258184402433
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48871,0.0517161347021671,0.0501788517566071,-0.0466344147407827,0.150066684145117,0.302724181098385
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48871,0.00356573736143204,0.0546378235178932,-0.103524396733639,0.110655871456503,0.947966589026734
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48871,-0.0252972587408894,0.0173221491951529,-0.0592486711633891,0.00865415368161017,0.144196264596101
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48871,-0.0124811968540142,0.0240357505628726,-0.0595912679572445,0.034628874249216,0.603573882687609
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48871,-0.0187210464991835,0.0127746721155982,-0.0437594038457561,0.00631731084738908,0.142805556271956
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35032,0.0273256336686296,0.0166187998944821,-0.00524721412455524,0.0598984814618145,0.100176278982509
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35032,-0.000911044835051913,0.0171934623631043,-0.0346102310667364,0.0327881413966326,0.95774339070546
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35032,0.0147934234055985,0.0246424816834702,-0.0335058406940032,0.0630926875052002,0.54831497464863
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35032,-0.00617403848313309,0.0100932314005225,-0.0259567720281573,0.0136086950618911,0.540759502162532
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38864,0.00901755920002917,0.00819046715394243,-0.007035756421698,0.0250708748217563,0.270931773966669
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38864,0.00143352516469603,0.00961622593475721,-0.0174142776674281,0.0202813279968202,0.881498686697055
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38864,-0.00718485036282479,0.00801689515061126,-0.0228979648580229,0.00852826413237328,0.370161009509945
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38864,-0.0122234049532216,0.0184816660746027,-0.0484474704594429,0.0240006605529997,0.508384384142233
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38864,-0.00749361496087802,0.0102665664196841,-0.0276160851434588,0.0126288552217028,0.465466127092535
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38864,-0.036387538349177,0.0148073997642659,-0.0654100418871383,-0.00736503481121584,0.0140125400093673
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48884,-0.00633666567319319,0.0170766672477522,-0.0398069334787876,0.0271336021324012,0.710588220129083
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48884,-0.0149916201654875,0.0129195021020711,-0.0403138442855468,0.0103306039545719,0.245905412996235
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48884,0.0180384335224633,0.0348093652666433,-0.0501879224001576,0.0862647894450842,0.604320139493606
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48884,-0.0189669111938413,0.0120259764144363,-0.0425378249661366,0.00460400257845392,0.114774353720468
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48884,-0.0054630027950116,0.0140539512518526,-0.0330087472486427,0.0220827416586195,0.697490075479219
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48884,-0.00878727900495399,0.0171091376426544,-0.0423211887845567,0.0247466307746487,0.607536383529543
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48884,-0.000191393715293512,0.00573507070060612,-0.0114321322884815,0.0110493448578945,0.973377868030949
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34063,0.011477329163799,0.0149858517701399,-0.0178949403056752,0.0408495986332731,0.443786214190643
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34063,0.00735534552113929,0.0186544689147723,-0.0292074135518143,0.0439181045940929,0.69338124312634
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34063,-0.00512943811091645,0.0128703376398305,-0.0303552998849842,0.0200964236631513,0.690244283466569
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34063,-0.00448164407236101,0.0120769992881228,-0.0281525626770817,0.0191892745323596,0.710587232139238
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48964,2.40137028244162e-05,0.00763164666671151,-0.0149340137639301,0.014982041169579,0.997489416155853
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48964,-0.0292742420839082,0.0214367288348658,-0.0712902306002452,0.0127417464324288,0.172076490942423
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48964,-0.00857622492511604,0.00639260152275323,-0.0211057239097124,0.00395327405948029,0.179745666435906
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48964,-0.0103898471256223,0.00615088835365364,-0.0224455882987834,0.00166589404753882,0.0912041497460368
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48964,-0.000688160254756734,0.0105072675739106,-0.0212824046996214,0.019906084190108,0.947781552291028
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48964,-0.0144588768555121,0.00785569802786086,-0.0298560449901193,0.000938291279095217,0.065701166726634
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48964,-0.0079210120383399,0.0064130239415741,-0.0204905389638251,0.00464851488714534,0.216791362717121
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48964,-0.00295570741860587,0.0197055638655151,-0.0415786125950154,0.0356671977578037,0.880771236562647
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43259,-0.012122305019966,0.00672499516804303,-0.0253032955493304,0.0010586855093983,0.071476458036367
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43259,0.00060390979834053,0.00699964423430583,-0.0131153929008989,0.01432321249758,0.931247280215244
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43259,0.0161427829769249,0.0073986566304664,0.0016414159812108,0.0306441499726391,0.0291368596036158
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43259,0.00628585155760984,0.0100259035698295,-0.013364919439256,0.0259366225544756,0.530694909111837
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43259,-0.0127005040850531,0.00674144661180297,-0.0259137394441869,0.000512731274080741,0.0595932356644217
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48774,-0.00642411728272176,0.00670301928285997,-0.0195620350771273,0.00671380051168378,0.337877169946746
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48774,0.00903412291996594,0.00545894675599196,-0.0016654127217783,0.0197336585617102,0.0979566514983682
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48774,0.000141536859298155,0.0056486684269159,-0.010929853257457,0.0112129269760533,0.980010011545994
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48774,0.0107831370062387,0.0123432667288659,-0.0134096657823386,0.0349759397948159,0.382344227759689
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48788,-5.34975285452864e-06,0.00607748208241555,-0.011917214634389,0.0119065151286799,0.999297664701219
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48788,0.00536062801723947,0.0119307026590146,-0.0180235491944292,0.0287448052289081,0.65321035428182
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48884,-0.00471270369425279,0.00553771204232821,-0.0155666192972161,0.00614121190871051,0.394768592781524
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48884,-0.00240773511341817,0.00632752888594434,-0.0148096917298691,0.00999422150303275,0.70356545562615
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48884,-0.016515029314412,0.00955623450582823,-0.0352452489458353,0.00221519031701135,0.0839690862515983
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48884,-0.0011803209465402,0.0133039348844811,-0.0272560333201231,0.0248953914270427,0.929305588099976
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48884,-0.0206349839120572,0.0169118676816021,-0.0537822445679974,0.0125122767438829,0.222423334904391
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48884,0.0200783473866645,0.0156734763860564,-0.010641666330006,0.050798361103335,0.200194766985046
CCND2,G1/S-specific cyclin-D2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40308,0.00415851529837291,0.00376578539853062,-0.0032224240827471,0.0115394546794929,0.269491710849337
CCND2,G1/S-specific cyclin-D2,Physical activities,X864.Number of days or week walked 10+ minutes,48474,0.0302150921487163,0.0357507377398596,-0.0398563538214084,0.100286538118841,0.39803202448903
CCND2,G1/S-specific cyclin-D2,Physical activities,X874.Duration of walks,45837,0.00406055522750641,0.00301171047924038,-0.00184239731180474,0.00996350776681756,0.177594566688929
CCND2,G1/S-specific cyclin-D2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47658,0.0683971060012566,0.0343561306878882,0.00105908985299583,0.135735122149517,0.0465146500260916
CCND2,G1/S-specific cyclin-D2,Physical activities,X894.Duration of moderate activity,43511,0.0159841790052205,0.0422462167429978,-0.0668184058110551,0.0987867638214961,0.705170539400822
CCND2,G1/S-specific cyclin-D2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32843,0.00862084543956162,0.00714117909810621,-0.00537586559272656,0.0226175564718498,0.227432619905281
CCND2,G1/S-specific cyclin-D2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47602,0.0342811534755222,0.0354342664673793,-0.0351700088005411,0.103732315751586,0.333327998411339
CCND2,G1/S-specific cyclin-D2,Physical activities,X914.Duration of vigorous activity,38823,0.00115543001290925,0.00369821349256622,-0.00609306843252055,0.00840392845833905,0.754721100574864
